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ABSTRACT 
 
The Selective Effect of Dietary n-3 Polyunsaturated Fatty Acids on Murine Th1 and Th2 
Cell Development. (August 2005) 
Ping Zhang, B.S., M.S., Renmin University of China, Beijing; 
M.S., Lund University, Sweden 
Co-Chairs of Advisory Committee: Dr. Robert S. Chapkin 
                                                             Dr. David N. McMurray 
 
       To examine how dietary n-3 polyunsaturated fatty acids affect Th2 cell 
development, female C57BL/6 mice were fed a washout corn oil (CO) diet for 1 wk 
followed by 2 wk of either the same CO diet or a fish oil (FO) diet. CD4+ T cells were 
isolated from spleens and cultured under both neutral (anti-CD3 and phorbol myristate 
acetate (PMA)) and Th2 polarizing conditions (anti-CD3 and PMA, in presence of rIL-4, 
rIL-2, and anti-IFN-γ) in the presence of homologous mouse serum (HMS) or fetal 
bovine serum (FBS) for 2 d. Dietary n-3 PUFA significantly enhanced Th2 cell 
development and suppressed Th1 development under neutral conditions as assessed by 
intracellular cytokine staining for IL-4 and IFN-γ as the two prototypic Th2 and Th1 
cytokines, respectively. However, under Th2 polarizing conditions, while the 
suppression of Th1 cells was maintained in FO-fed mice, no dietary effect was observed 
in Th2 cells. Dietary FO increased the Th2/Th1 ratio under both neutral and Th2 
polarizing conditions with HMS in the cultures. To examine the effect of dietary n-3 
PUFA on Th1 development, DO11.10 Rag2-/- mice expressing transgenic T cell receptor 
specific for ovalbumin (OVA) peptide were used. CD4+ T cells were isolated from 
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spleens and lymph nodes and stimulated with ovalbumin (OVA) peptide and irradiated 
BALB/c splenocytes in the presence of rIL-12, anti-IL-4, and rIL-2 in HMS for 2d. Cells 
were expanded for another 3 d in the presence of rIL-2 and rIL-12. Dietary n-3 PUFA 
did not affect Th1 differentiation as assessed by the proportion of IFN-γ+, IL-4- T cells in 
the cultures, but suppressed rIL-2 induced expansion. The suppressed expansion was due 
to suppressed proliferation (p<0.05). In vivo expansion of antigen-specific T cells was 
visualized by flow cytometric analysis of CFSE-positive transgenic T cells. Dietary n-3 
PUFA did not appear to affect antigen-induced CD4+ T cell cycle progression in vivo. 
Overall, these results suggest dietary n-3 PUFA have no direct effect on Th2 cell 
development but do directly suppress Th1 cell development following both mitogenic 
and antigenic stimulation in vitro. 
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CHAPTER I 
INTRODUCTION 
BACKGROUND 
PUFA and chronic inflammatory diseases 
       Many epidemiological and clinical studies have demonstrated that dietary fish oil 
(FO) attenuates immune-mediated inflammatory diseases (1-3).  The principal bioactive 
constituents of FO are considered to be eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA). Initial evidence for an anti-inflammatory effect of FO 
came from an epidemiological study showing a very low incidence of certain chronic 
inflammatory diseases in Greenland Eskimos whose diets are rich in EPA and DHA 
from fish (4). Subsequently, many clinical trials also showed that FO supplementation 
resulted in clinical improvement in a number of Th1-related chronic diseases such as 
rheumatoid arthritis (RA), Crohn’s disease, ulcerative colitis, psoriasis, lupus, and 
multiple sclerosis (5,6). Evidence is strongest in RA, which is accompanied by 
production of high levels of inflammatory cytokines such as IL-1, IL-6, IL-8, and TNF-α 
(7,8). These cytokines and arachidonic acid (20:4n-6, AA)-derived eicosanoids such as 
PGE2, LTB4, and 5-HETE are found in synovial fluids of joints of RA patients (9,10). 
Reduced expression of COX 2, TNF-α, and IL-1 could explain in part the benefits of FO  
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in RA (5). Most of the 13 published clinical trials of FO treatment in RA showed a 
statistically significant benefit (11), thus, justifying the recommendation to include FO in 
the treatment of RA (12). The benefits of FO also include reduced risky cardiovascular 
disease (13). The widely used methotrexate and sulfasalazine for RA increase serum 
levels of homocysteine, which poses a risk for cardiovascular diseases. N-3 PUFA have 
been proven to reduce mortality in coronary heart disease (14).  
       Dietary FO has also been shown to be beneficial in various animal models of human 
Th1-mediated diseases (6). In mice with autoimmune glomerulonephritis (a model of 
lupus), FO feeding increased survival and decreased proteinuria and auto-antibodies 
(15,16). In collagen-induced arthritis, FO feeding decreased joint inflammation in 
rodents (17). In the rat model of colitis, dietary FO reduces inflammation (18). These 
clinical improvements were accompanied by reduced production of proinflammatory 
cytokines and increased anti-inflammatory cytokines. 
       There is currently considerable interest in FO supplementation for asthma, a typical 
Th2-mediated chronic inflammatory disease (19). There has been a dramatic increase in 
the prevalence of childhood atopic disease in developed countries over the past 30 years 
and it is attributed, at least in part, to increased dietary intake of n-6 PUFA (20,21). 
Supplementation with FO in pregnant women decreased allergy-specific cytokines and 
the severity of atopic dermatitis in their infants (22). There is also epidemiological 
evidence to support a protective role of dietary n-3 PUFA in atopic diseases. For 
example, surveys in the United Stated found that dietary fish oil intake was associated 
with better lung function (11). School children in Australia who consumed oily fish 
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regularly had a much lower likelihood to develop asthma than those who did not include 
oily fish in their diets (20). In asthma, the AA-derived 4-series leukotrienes (LT) 
produced by mast cells are major mediators of asthmatic bronchoconstruction. Although 
n-3 PUFA supplementation could reduce 4-series LT, limited clinical effects were 
observed. The role of n-3 PUFA in asthma still needs to be clarified by well-designed, 
placebo-controlled intervention studies (11).  
 
T cell activation and differentiation 
       T cell-dependent immune responses begin with the binding of the T cell receptor 
(TCR) on a naïve T cell with an antigen presenting cell (APC) which has captured an 
antigen (23). Soluble antigens must be processed by APC and then re-expressed as 
peptide fragments on the surface of APCs bound to major histocompatibility complex 
(MHC) class I and class II molecules. The TCR signal requires additional support by co-
stimulatory signals and adhesion receptors to amplify and prolong the activation events. 
The T cell homodimer, CD28, serves an important role in ensuring maximal clonal 
expansion and differentiation. In vivo, T cells from mice lacking CD28 (or both B7-1 
and B7-2, the ligands for CD28 binding on the APC) showed impaired priming with 
subsequent weak memory responses (24). In vitro, T cells lacking CD28 costimulation 
proliferate poorly and showed reduced activation in all transcription factors expressed 
early in T cell activation. For induction of a primary CD4+ T cell response, two signals 
are required. One is the antigen-associated MHC class II molecule on the surface of the 
APCs, and the other is a costimulatory signal delivered by the APCs (25). Upon 
 4
 
activation, “professional APCs” such as dendritic cells (DCs), macrophages and B cells, 
upregulate surface B7-1 and B7-2, which bind to CD28. 
       T cells can be divided into CD4+ and CD8+ subsets based on the unique expression 
of these molecules on the cell surface. Both CD4+ and CD8+ T cells can further 
differentiate into polarized Th1/Th2 or Tc1/Tc2 effector cells. Mouse Th1 cell cytokines 
include IL-2 and IFN-γ, whereas Th2 cells express IL-4, IL-5, IL-10, and IL-13 (26). 
The cytokines of the Th1 and Th2 subsets mutually inhibit the differentiation and 
functions of the reciprocal phenotype. IFN-γ produced by Th1 cells selectively inhibits 
proliferation of Th2 cells, and IL-10 produced by Th2 cells inhibits Th1 cytokine 
synthesis (27). Correlated with their distinctive cytokines, Th1 and Th2 cells have 
different functions. Th1 cells are pro-inflammatory and are important in cell-mediated 
immunity against intracellular microorganisms. Th1 cells have been shown to be 
associated with the pathogenesis of autoimmune diseases such as RA, Crohn’s disease, 
and insulin-dependent diabetes mellitus (IDDM) (26,28). Th2 cells promote antibody 
secretion, particularly the IgE response, and also enhance eosinophil proliferation and 
function. Therefore, Th2 cells are often associated with allergic reactions and are 
important in defense against extracellular pathogens (27).  
       Many factors have been shown to influence the outcome of Th1/Th2 differentiation. 
Cytokines are critical inducers of Th subset development (27). IL-12 directs the 
development of Th1 cells while IL-4 drives Th2 development. IL-12 is produced by 
macrophages following stimulation by microbial products including LPS and 
intracellular bacteria such as Listeria monocytogenes and mycobacteria. Specific 
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dendritic cells in the spleen seem to be able to bias Th1 or Th2 development by eliciting 
different cytokines (29). CD8α+ DCs produce IL-12 and induce IFN-γ and IL-2, while 
CD8α- DCs induce IL-4 production.   
       Some other factors which affect Th1 and Th2 differentiation include genetic 
background of the host, the route and dose of antigen immunization, cell cycle, and 
nutritional status. Using a murine TCR transgenic system, Hsieh et al showed that 
genetic background has a profound impact on T helper cell differentiation (30). This 
TCR transgenic model makes it possible to study Th1/Th2 differentiation under well-
controlled conditions. DO11.10 α/β-TCR mice which express a transgenic T cell 
receptor specific for OVA peptide on BALB/c, B10.D2 or DBA/2J backgrounds were 
generated and the development of Th1 and Th2 differentiation was examined in vitro by 
culturing CD4+ T cells from these mice. Purified CD4+ T cells from these mice were 
stimulated under similar conditions, using BALB/c splenocytes as APC loaded with 
OVA peptide. Upon restimulation, the IL-4 levels were three to five-fold higher from 
transgenic T cells on BALB/c background compared with those from B10.D2 
background. In contrast, IFN-γ levels were two to three fold higher in transgenic T cells 
from B10.D2 mice compared with those from BALB/c mice. These cytokine profiles 
existed even after repeated stimulation of T cells, indicating that the phenotypes were 
stable. However, the cytokine profiles were not significantly different between different 
strains after 48 h in culture, suggesting that B10.D2 T cells do not express the Th1 
phenotype when isolated fresh, however, they have a predisposition to differentiate into 
Th1 cells under neutral or default conditions in vitro. Further evidence came from 
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experiments in which T cells from both backgrounds were primed with APCs from each 
background (30). BALB/c T cells produced much higher levels of IL-4 and lower levels 
of INF-γ than T cells from B10.D2 mice, when primed either with APCs from BALB/c 
mice or B10.D2 mice. Thus, the difference between these two backgrounds for Th 
phenotype appears to reside within the T cell rather than within the APC (30). 
       Different adjuvants drive T cell differentiation along the type-1 or type-2 pathway 
(31). When tested with hen egg white, a prototypic Ag, Complete Freund’s Adjuvant 
(CFA) always induced Th1 cytokines while Incomplete Freund’s Adjuvant (IFA) 
stimulated Th2 cytokine production. These adjuvants can overcome the influence of 
genetic background and antigen type. For example, in both Th1-prone B10.D2 mice and 
Th2-biased BALB/c mice, injection of Ag with IFA resulted in IL-5 production upon 
restimulation, while immunization in CFA induced high levels of IFN-γ production in a 
recall response. The unipolar cytokine response was consistent with antigens that have 
intrinsic Th1/Th2 polarizing effects such as Th1-biased Leishmania and Th2-biased 
Schistosoma egg Ags. Alum, the only adjuvant generally used in human vaccines, is a 
type-2 adjuvant that stimulates the same humoral but a weaker cellular type-2 immunity. 
Injection of Alum into both BALB/c and B10.D2 mice resulted in the same 
concentrations of IgG1 but not IgG2a as IFA did, but the recall response of IL-5 
production was much lower than IFA. The intrapertoneal (i.p.) route seems to favor a 
Type-2 cellular response, as evidenced by more IL-5-producing cells, for both IFA and 
alum. 
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        Neonates are biased towards type-2 immunity and shift progressively toward type 1 
during the first year (32). Peptide dose and affinity influences Th1 or Th2 cytokine 
production in an opposite way depending on short term or long term stimulation (33). 
Th1 differentiation increased with cell cycle progression whereas Th2 differentiation 
only occurred after 3 rounds of cell division (34). Leishmania major infection induces a 
Th1 response while helminth infection triggers a Th2 response (27). 
        Some dietary components and nutritional status have been found to affect Th1/Th2 
differentiation including intracellular thiols status, vitamins A, D, and E, and dietary 
ribonucleotides. More intracellular thiols inhibited Th1 cytokine production and 
increased IL-4 production (35). Vitamin A enhanced Th2 development (36). Vitamin E 
suppressed IL-4 production in an animal model of allergy and AIDS (37). Dietary 
ribonucleotides skewed Th2 response to OVA towards Th1 in young BALB/c mice  
(38).  Vitamin D suppressed both Th1 and Th2 cytokines (39). Understanding the role of 
nutrients in influencing the outcome of Th1/Th2 differentiation could help promote diet 
as adjunct therapy for Th1/Th2 mediated chronic inflammatory diseases. 
       The molecular basis for Th1 and Th2 differentiation has been elucidated in the past 
20 years (40,41). IL-12 and IL-4 act through STAT-4 and STAT-6 to direct Th1 and Th2 
differentiation, respectively. Gata-3 is probably a master regulator of Th2 differentiation 
(41). Ectopic expression of Gata-3 promotes Th2 differentiation under conditions that 
otherwise induce Th1 development. Gata-3 can program transcriptionally permissive 
chromatin structure within the IL-4 locus.  Analogous to Gata-3 to direct Th2 
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differentiation, T-bet is a Th1-specific transcription factor. Ectopic expression of T-bet 
in developing Th2 cells promotes Th1 differentiation (41).  
       Beside differences in cytokine profiles, Th1 and Th2 cells have some other 
distinctive properties. Th1 cells, but not Th2 cells, bind to P and E-selectin and can 
efficiently enter inflamed skin and arthritic joints (42). Th1 and Th2 cells exhibit 
different degrees of susceptibility to apoptosis. Th1 cells are more susceptible to 
activation-induced cell death (AICD) whereas Th2 cells are relatively resistant to AICD 
(43). The signaling events in polarized Th1 and Th2 cells are quite different (44). Th2 
cells showed decreased ZAP-70 phosphorylation and calcium signaling. Th1 and Th2 
cells also exhibited differences in the compartmentalization of lipid rafts (45). For 
example, Th1 cells recruited both the TCR/CD3 complex and CD45 to rafts upon 
stimulation, whereas the TCR was not stably associated with lipid rafts in Th2 cells.  
 
T cell activation by antigen  
      A primary CD4+ T cell response can be divided into three distinct phases: activation, 
proliferation, and differentiation (46). Upon stimulation, CD4+ T cells are activated, and 
progress through several rounds of cell division in a process called clonal expansion. 
During the clonal expansion, T cells progressively differentiate into specialized effector 
cells with the capacity to rapidly produce high levels of cytokines after a reencounter 
with Ag.  However, each of these phases may occur sequentially or simultaneously. 
Which stimulatory signals are required to trigger each phase and the sequence of the 
signals during the whole process is still unclear.  
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      The activation phase occurs before division. There is at least a 24-h lag while a 
resting T cell becomes activated and progresses through the cell cycle. During this 
period, many genes and their products are expressed to prepare for DNA replication and 
cell division. Epigenetic remodeling to turn on polarized cytokine genes is among the 
earliest change which occurs during T cell activation. That is why cytokines which drive 
polarization are most effective when present at the initiation of T cell activation before 
the first round of cell division. 
       Once cell proliferation starts, activated T cells divide rapidly and can continue 
through multiple rounds of division, resulting in clonal expansion of the initial 
population. After an initial lag period, stimulated CD4+ T cells divide at a constant rate, 
with a doubling time of 4-6 h. The APCs present initially in the cell culture were 
nonviable at 60h. Differentiation also occurs during effector cell generation. The factors 
influencing the differentiation of naïve CD4+ T cells into polarized effector cells have 
been discussed above.  
       A significant level of cell death occurs throughout effector cell generation when 
CD4+ T cells are stimulated with Ag and APCs in culture, resulting in lower effector 
recoveries than would be predicted if all of the cells generated survived the 4-day culture 
(46). Similar cell death also occurred in T cell lines (47). 
      Much attention has been given to the role of Ag in driving the immune response. Ag 
concentration is related to both the extent and duration of TCR engagement (46). 
Extended signaling is necessary for commitment to CD4+ T cell proliferation. Ag 
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concentration also determines whether differentiation favors effector vs. memory cell 
development, and affects the Th subset development (46). 
       While Ag is clearly required to initiate clonal expansion, its role in maintaining the 
process has been revealed only recently. Lee et al investigated the subsequent effects of 
Ag on clonal expansion (48). Murine CD4+ T cells were labeled with carboxyflurescein 
diacetate succinimidyl ester (CFSE) and were stimulated with specific peptide Ag. 
Separation of proliferating cells based on CFSE fluorescence intensity showed that 
daughter cells from each cell division proliferated after removal of Ag. As short as a 2 h 
exposure to peptide was sufficient to induce proliferation of OVA-specific DO11.10 
CD4+ T cells after subsequent removal of OVA. These data suggest that continued 
antigen stimulation is not required during the clonal expansion of CD4+ T cells. 
       Full development of effector function requires 4 d of in vitro culture and, similarly, 
4 or more days are required to generate fully activated T cells in vivo (46). Using vital 
dyes and FACS analysis, two distinct stages in the transition from naïve CD4+ T cells to 
effector cells have been identified, an early antigen-dependent stage and a late cytokine-
driven expansion and differentiation stage. Efficient peptide presentation by professional 
APC to naïve and effector CD4+ T cells is limited to the first 1-2 days of culture and 
promotes optimal proliferation and effector expansion during culture. A short duration 
(1-2 d) of TCR stimulation in the presence of growth-promoting and polarizing 
cytokines is both sufficient and optimal to promote the development of a stable cytokine 
profile. In fact, prolonging Ag presentation leads to high level of T cell death, decreased 
effector expansion, and decreased cytokine production by recovered effectors. A TCR 
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stimulation-independent expansion phase exists during the late phase (d 2-4) of effector 
generation and is dependent on IL-2 (46). These studies suggest that optimal CD4+ 
effector generation occurs when there is an initial 1-2 d of Ag presentation followed by 
an Ag-independent and IL-2 driven cell expansion phase lasting an additional 2 d. 
 
Methods to evaluate the effect of fatty acids on lymphocyte function 
       Various methodologies are available to assess the effect of fatty acids on 
lymphocyte function including in vitro, ex vivo, and in vivo studies (6). In the in vitro 
studies, fatty acids or other metabolites of lipids such as PGE2 are added to cultured 
lymphocytes. Although non-physiological in nature, this kind of study can provide 
insight into the mechanisms of fatty acid action on lymphocytes. The ex vivo studies are 
so called because experimental diets are fed to animals or humans followed by isolation 
and culture of lymphocytes to study the changes induced by feeding. This ex vivo 
approach is also somewhat artificial, however, the lymphocytes have undergone diet-
induced changes within the animal or human host, thus better reflecting physiological 
changes caused by fatty acids in lymphocytes. In addition, the ex vivo approach also 
provides the advantages of examining the function of specific cell types and possible 
mechanisms. The challenge for the ex vivo study is to isolate lymphocytes in sufficient 
purity and subsequently to culture them. For animal studies, lymphocytes from blood, 
spleen, thymus, lymph nodes, lungs, and gut-associated lymphoid tissue. Either mixed 
cell population like whole splenocytes or purified lymphocyte subsets (e.g., CD4+ T cells 
and CD8+ T cells) have been studied. In human studies, the ex vivo approach is limited 
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to blood lymphocytes, often as a mixture with monocytes. Preparations of human blood 
generate a mixture of 85-90% lymphocytes and 10-15% monocytes and are described as 
mononuclear cell preparations. Finally, certain indicators can be employed to examine 
diet-induced changes of lymphocyte function in vivo, e.g., the number of different types 
of lymphocytes, the cell surface expression of certain activation markers such as the 
adhesion molecules, etc. In animal studies, the weight, size, and cellularity of various 
lymphoid organs can be determined. Circulating cytokines, cytokine receptors and total 
Ig and Ig subclasses in the blood can also be quantified. Secretory IgA can be found in 
extracellular fluids and can be measured in saliva, tears, and intestinal washings. The in 
vivo cell-mediated immune response can be determined by responses to antigenic 
challenge (e.g., the delayed-type hypersensitivity (DTH) response). Skin graft rejection 
has also been used in animal studies as an in vivo indicator of cell-mediated immune 
function.  
 
Adoptive transfer 
       The in vivo clonal expansion of T cells of known specificity in response to antigen 
can be visualized by an adoptive transfer technique that was first developed by Kearney 
et al. (49). Transgenic T cells from DO11.10 TCR transgenic donor mice were 
transferred intravenously into normal BALB/c recipient mice. The transferred T cells 
can be detected by staining lymph nodes cells with anti-CD4 and the KJ1-26 mAb. The 
transferred T cells represented a very small population but they can increase 
dramatically after subcutaneous injection of the ovalbumin (OVA) 323-339 peptide in 
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CFA. The increase was attributed to the expansion of transferred cells and not to recent 
thymic emigrants. This adoptive transfer protocol has been used to study the behavior of 
antigen-specific T cells following immunization. It was found that the response 
following subcutaneous injection could be characterized by marked accumulation of 
antigen-specific cells only in the draining lymph nodes. Three days after subcutaneous 
injection of 300 µg of ovalbumin in CFA at three sites on the back, the percentage of 
CD4+, KJ1-26+ T cells increased markedly in the brachial lymph nodes (49). After 17 
days, the CD4+, KJ1-26+ T cells fell to about one third of day 3 level.  
       In vivo proliferation of these cells can be visualized by adoptive transfer of 
carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled DO11.10 T cells. 
Without immunization, the KJ1-26+ T cells are identified as a single CFSE-positive 
peak. In contrast, the KJ1-26+ T cells showed several cell divisions in the immunized 
host (48). 
      Using the adoptive transfer protocol, Anderson et al. studied the effect of dietary 
lipids on in vivo proliferation of antigen-specific naïve CD4+ T cells (50). The expansion 
of CD4+ KJ1-26+ T cells in draining lymph nodes was detected by flow cytometry. Four 
weeks of feeding a FO diet (20% total fat) to recipient mice resulted in less in vivo 
proliferation of CD4+ T cells compared with a soybean oil diet.  
 
Measures for function of isolated lymphocytes 
       There are a few widely used methods to measure the function of isolated 
lymphocytes. Proliferation is the most common indicator of lymphocyte function (6). 
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This is often assessed by incorporation of 3H-labeled thymidine into the DNA of 
dividing lymphocytes. Since its introduction in 1994, the flow cytometric analysis of 
lymphocyte proliferation by CFSE labeling has gained popularity and is now widely 
used in immunological laboratories around the world (51,52). This method allows 
determination of eight to ten cell divisions, both in vitro and in vivo. The generally used 
incorporation of tritiated thymidine can only quantify overall division and therefore does 
not reflect the division history of cells. The fluorescein based dye CFSE has the 
biochemical properties that make it perfectly suited to this application. CFSE consists of 
a fluorescein molecule containing two acetate moieties and a succinimidyl ester 
functional group. It is membrane permeable, colorless and nonfluorescent. After CFSE 
passively diffuses into cells, its acetate groups are cleaved by endogenous esterase to 
yield highly fluorescent, carboxyfluorescein succinimidyl ester. The succinimidyl ester 
groups react with intracellular amines to form fluorescent conjugates, which are well 
retained in the cells. When cells divide, CFSE is distributed equally between the parent 
and daughter cells and is not transferred to adjacent cells. Thus, each successive 
generation in a proliferating population is marked by a 50% decrease in cellular 
fluorescence intensity that is readily identified by flow cytometry. This technique has 
been widely used to track in vitro cell proliferation in cell culture and in vivo division of 
adoptively transferred cells. CFSE has the same spectral characteristics as fluorescein, 
thus it can be used with monoclonal antibodies conjugated to phycoerythrin (PE) or PE-
Cy5 to identify the phenotype of dividing cells. 
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        Agents which stimulate lymphocyte proliferation include mitogens such as 
concanavalin A (ConA) and phytohaemagglutinin (PHA), which stimulate T cells, 
pokeweed mitogen, which stimulates a mixture of T and B cells, and bacterial 
lipopolyssaccharide (LPS) which stimulates B cells (6). T cells can be stimulated with 
anti-CD3 or a combination of anti-CD3/anti-CD28, or a combination of phorbol-12-
myristate-13-acetate (PMA) that stimulate protein kinase C and Ionomycin, which 
triggers a rise in the intracellular free calcium concentration.  Antigen can also be used 
to stimulate T cells. However, in the past, this could be done only if the animal or 
individual had been sensitized to an antigen. This is due to the incredibly low frequency 
of lymphocytes specific for any given antigen in a naïve host (estimated to be < 1 in 105 
lymphocytes) (53). Immunization of the host causes the expansion of antigen-specific T 
cells. The presence and function of antigen-specific T cells can be studied after such in 
vivo priming. However, transgenic mice expressing a transgenic T cell receptor for a 
specific peptide facilitate the study of antigen-specific T cell activation (50). In general, 
TCR transgenic mice contain a much higher number of naïve, antigen-specific T cells, 
and the naïve T cells can be stimulated directly with antigen. Among many TCR 
transgenic mouse models, the DO11.10 TCR transgenic mouse is widely used to study 
antigen-specific T cell activation and differentiation (54). The DO11.10 transgenic 
mouse expresses a T cell receptor specific for a peptide from ovalbumin (OVA 323-339) in 
an MHC class II-restricted fashion. Whole splenocytes from DO11.10 mice can be 
stimulated with OVA peptide or the purified CD4+ T cells and stimulated with OVA 
peptide in the presence of antigen-presenting cells, usually irradiated BALB/c 
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splenocytes (30). Th1 and Th2 differentiation can be studied by adding Th1 or Th2 
polarizing cytokines and antibodies (55). To study antigen-specific T cell activation in 
vivo, T cells from DO11.10 mice can be adoptively transferred to recipient mice through 
tail vein injection and the recipient mice are then immunized (49). Upon immunization 
with the OVA 323-339 peptide, the transferred T cells undergo a primary T cell response 
that can be tracked using a monoclonal antibody specific for the DO11.10 T cell receptor 
(KJ1-26). The draining lymph nodes can be isolated and stained with KJ1-26. Expansion 
of TCR positive T cells can be visualized by flow cytometric analysis. In addition, cell 
division can be tracked by the CFSE intensity of KJ1-26+ T cells. These features make it 
possible to accurately study the expansion and differentiation of Ag-stimulated T cells in 
vivo. 
  
Effect of n-3 PUFA on immune function 
       PUFA are categorized according to the position of the last double bond relative to 
their methyl end into two classes: n-3 and n-6. Mammals cannot introduce double bonds 
between carbon 9 and the methyl end of fatty acids, they can neither synthesize PUFA 
nor convert n-6 into n-3 PUFA. Thus, they must be obtained through the diet (14). Most 
common dietary n-6 PUFA include linoleic acid (LA: 18:2n-6), γ-linolenic acid (GLA: 
18:3n-6) and arachidonic acid (AA: 20:4n-6). LA is readily converted to AA via GLA. 
AA is the precursor of eicosanoid messengers, which are potent mediators of 
inflammation. Among dietary n-3 PUFA, α-linolenic acid (ALNA; 18:3n-3) is found in 
green leafy vegetables, walnut and flaxseed oils, while EPA (20:5n-3) and DHA (22:6n-
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3) are found in cold-water fatty fish such as tuna, salmon, mackerel and herring. Diet can 
influence the process of chronic inflammatory diseases. The typical Western diet 
contains 10-20 times more n-6 than n-3 PUFA (56). This imbalance has been associated 
with progression of cardiovascular disease (19). Thus, this forming the basis for the 
American Heart Association’s recommendation that adult eats fish at least twice a week 
to prevent cardiovascular diseases. 
        In general, PUFA exert immunomodulatory and anti-inflammatory effects, and the 
effects of n-3 PUFA are considered more pronounced compared to those of n-6 series. 
N-3 PUFA exert anti-inflammatory effects through a variety of mechanisms (14). First, 
alterations of lipid messengers by n-3 PUFA have been regarded as a primary 
mechanism of action of n-3 PUFA on immune faction. Fatty acids in the diet are 
incorporated into the plasma membranes of immune cells. The changes in fatty acid 
composition of lymphocyte membranes directly affect some lipid messengers that are 
derived from membrane fatty acids. Usually, AA is liberated from the membrane in 
response to stimuli. AA is metabolized by cyclooxygenases (COX) to generate 
prostaglandins (PGs) and thromboxanes of the 2-series. N-3 PUFA can interfere with 
eicosanoid production from AA and generate less effective messengers, the 3-series of 
PGs. Dietary n-3 PUFA are incorporated into the plasma membranes at the expense of 
AA. PUFA compete with AA for the same enzymes, but they are poor substrates. In 
addition to inhibition at the enzymatic level, n-3 PUFA also inhibit gene expression of 
COX-2. Although lymphocytes are a poor source of eicosanoids, the PGs have a 
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profound impact on their function. For example, PGE2 derived from macrophages 
inhibits lymphocyte proliferation and Th1 cytokines (11,57,58). 
       PUFA also regulate gene expression directly through binding nuclear receptors or 
indirectly by altering signaling pathways. Peroxisome proliferation-activated receptor 
(PPAR) was originally found to be a key regulator of adipocyte differentiation. Its role in 
the regulation of lymphocyte function was only recently reported (59). PPARγ is the 
most abundant isoform expressed in myeloid cells, whereas PPARα is predominantly 
expressed in lymphocytes (59). It is noteworthy that PPARγ is up regulated during T cell 
activation at the expense of PPARα. Both PPARγ and PPARα agonists inhibit IL-2 and 
IFN-γ in murine and human lymphocytes, although the PPARα agonists is less potent 
than PPARγ agonists (59). PPAR α can be activated by many fatty acids whereas PPAR 
γ has selectivity for some unsaturated fatty acids and their derivatives. However, nuclear 
receptor involvement does not explain the stronger anti-inflammatory effects of n-3 
compared to n-6 PUFA (14).  
        Recently, modulation of lipid rafts by n-3 PUFA was revealed as a novel 
mechanism for their immunosuppressive effect (14). Membrane lipid rafts are specific 
detergent-resistant domains within the plasma membrane that play an essential role in T 
cell signal transduction. Lipid rafts are characterized by a high content of cholesterol and 
sphingolipids, such as sphingomyelin and glycolipids (60). Numerous proteins involved 
in T cell signaling such as the linker for activation in T cells (LAT) are highly enriched 
in rafts (61). Early mediators of T cell proliferation, such as PKCθ, and of T cell 
apoptosis such as Fas and Fas-ligand, translocate to lipid rafts after stimulation. There is 
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overwhelming evidence that lipid raft integrity is a prerequisite for optimized TcR signal 
transduction and the subsequent immune response. Conditions that modify raft structure 
can disrupt the earliest steps of T cell activation. Polyunsaturated fatty acids such as 
EPA have been shown by in vitro studies using a Jurkat T cell line to displace acylated 
signaling proteins from membrane lipid rafts predominantly due to altered raft lipid 
composition. Treatment of cultured T cells with n-3 PUFA causes incorporation of n-3 
PUFA into lipids of the cytoplasmic leaflet of lipid rafts, resulting in displace acylated 
proteins (62). Treatment of Jurkat and human peripheral T cells with n-3 PUFA results 
in inhibition of LAT phosphorylation and downstream signaling events such as calcium 
response, JNK and NF-AT activation (63). However upstream events, such as CD3δ 
phosphorylation and ZAP-70 recruitment to the CD3 complex, are not affected. LAT 
displacement from lipid rafts has been shown to be a major molecular mechanism by 
which n-3 PUFA inhibits T cells (63). Recent studies indicate that the macromolecular 
complex organization in lipid rafts is distinct in Th1 and Th2 subsets (45). It is thought 
that the TcR may be pre-committed to respond differently depending on the 
differentiative state of the T cell and the regulation of T cell activation may be distinct in 
different T helper subsets. We have demonstrated that dietary n-3 PUFA remodel both 
raft and non-raft membrane composition in murine splenic T cells (64). However, the 
ability of n-3 PUFA to influence partitioning of signaling proteins in relation to T-cell 
subset activation in vivo has not been determined to date. 
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The role of lipid rafts in regulating IL-2R signaling 
        IL-2 is produced by T cells upon activation and is a potent T cell growth factor.  IL-
2 binds to the high affinity IL-2 receptor, which consists of an α (CD25), a β (CD122), 
and a γ chain (CD132) (65). The α chain is only expressed after stimulation through 
TCR or with IL-2 and is distinct from other cytokine receptors. Although it is not 
directly involved in IL-2 signaling, the IL-2 Rα chain enhances the affinity of the 
receptor. In contrast, although the β and γ chains mediate signal transduction, they are 
members of the hematopoietin-cytokine receptor superfamily and participate in receptors 
for other cytokines.  
       Recently several lines of evidence indicated the involvement of lipid rafts in the 
regulation of IL-2 R signaling. First, the importance of the rafts in IL-2 signaling was 
demonstrated by attenuation of the IL-2 signal in spleen cells of complex ganglioside-
lacking mice (66). Mutant mouse lines were established that completely lacked 
GM2/GD2 synthase activity and, thus, expressed no complex gangliosides. The sizes 
and cellularities of spleen and thymus of the mutant mice were significantly reduced. 
Spleen cells from these mice exhibited a dramatic decrease in proliferation when 
stimulated with IL-2, but not with ConA or anti-CD3. Expression of IL-2 Rα, β and γ 
chains was not different between the mutant mice and wild type mice. Up-regulation of 
IL-2 Rα was also normal in mutant mice. Activation of JAK1, JAK3 and STAT5 after 
IL-2 stimulation was reduced. Also, c-fos expression was delayed and reduced in mutant 
mice, but c-myc expression appeared to be normal compared with wild type mice. The 
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attenuated IL-2 signaling in mutant mice could be attributed to modulation of IL-2 
receptors by the lack of complex gangliosides. 
          Second, it has been demonstrated that antibody or ligand-mediated immobilization 
of components of lipid rafts, glycosyl-phosphatidyl-inositol (GPI)-anchored proteins and 
the GM1 ganglioside inhibit IL-2 induced T cell proliferation (67). IL-2 Rα is 
constitutively enriched in rafts and further enriched upon raft immobilization with anti-
Thy-1. In contrast, IL-2 Rβ and IL-2 Rγ were localized to the soluble fractions. JAK1 
and JAK3, which are constitutively associated with the IL-2 Rβ and IL-2 Rγ, also 
occurred in soluble membranes. In addition, IL-2-induced tyrosine phosphorylation of 
JAK1 and JAK3 are also localized to soluble fractions.  IL-2 induced heterotrimerization 
of IL-2 R chains occurs within soluble membrane fractions. Disruption of lipid raft 
integrity has little effect on IL-2 induced signaling (67). Using 125I-labeled IL-2, all three 
IL-2 R chains were identified in soluble membranes. In addition, disruption of the 
integrity of lipid rafts by methyl-β-cyclodextrin (MCD) did not inhibit IL-2 induced 
tyrosine phosphorylation of JAK1 and JAK3 in CTLL-2 cells. TCR-induced tyrosine 
phosphorylation of PLCγ-1 was ablated by MCD (68). These results suggest that IL-2R 
signaling occurs in soluble fractions of the plasma membrane (67).  Lipid rafts may 
regulate IL-2 R signaling by segregating elements of the receptor complex in the plasma 
membrane. IL-2 binding may result in the dissociation of IL-2 Rα from lipid rafts and its 
interaction with IL-2 Rβ and IL-2 Rγ chains in soluble membranes to initiate signaling. 
Immobilization of raft components impairs the mobility of IL-2 Rα and prevents the 
dissociation from rafts. It is therefore likely, that IL-2R α is in a dynamic equilibrium 
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between rafts and soluble membranes, and immobilization of raft components may shift 
the equilibrium by trapping the IL-2 Rα in lipid rafts (67). In contrast with above 
findings, IL-2 Rβ was found selectively enriched in rafts in untreated human T cells, but 
exposure to IL-2 resulted in partial translocation into soluble fractions (67). Disruption 
of rafts by MCD decreased surface expression of IL-2 Rβ. Several IL-2 Rβ associated 
kinase and adaptor molecules colocalize with IL-2 Rβ chain before and after IL-2 
stimulation. 
       Third, the distribution of IL-2 R on the T cell plasma membrane is not random.  
Using immunogold staining and electron microscopy, IL-2 Rα has been found to exhibit 
nonrandom surface distribution on human lymphoma cells and this clustering is 
independent of IL-2 (69). Clustering was also confirmed by confocal microscopy. IL-2 
Rα was found to be cocluster with MHC and CD48, which are known to localize in lipid 
rafts (69). Thus, IL-2 Rα was localized to cell surface clusters that appear to be lipid 
rafts. Disruption of rafts with filipin or MCD resulted in blurring of cluster boundaries 
and appeared to disperse the clusters for all four proteins. The three IL-2 R chains appear 
to form pre-existing complexes on the surface of T cells, brought closer together upon 
IL-2 binding, resulting in the aggregation of β and γ and the initiation of signaling (69). 
 
n-3 PUFA regulation of T cell function and rational for proposed studies 
       The significant effects of dietary n-3 PUFA on T cell function have been well 
documented in both human and experimental animals (3,6,70-72). In general, increased 
intake of n-3 PUFA is associated with reduced T cell proliferation in response to 
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mitogenic stimuli, and impaired production of a critical growth factor of T cells, 
interleukin-2 (IL-2). For example, dietary supplementation with 2.4-18 g/d EPA and 
DHA significantly reduced mitogen-stimulated proliferation and IL-2 production in 
human peripheral blood mononuclear cells (PBMC) (71). Mice fed 10g/kg EPA or DHA 
for as short as 10 d exhibited a significant decrease in ConA-stimulated splenocyte 
proliferation accompanied by a decrease in IL-2, and IL-2 Rα expression, and a 
reduction in DAG and ceramide (73). More recently, Arrington et al. reported decreased 
IL-2 secretion from purified CD4+ T cells from mice fed diets containing 1% DHA when 
cultures were stimulated with anti-CD3/anti-CD28. In contrast, FO feeding increased 
CD4+ T cell proliferation when cells were stimulated with anti-CD3 plus PMA (74). 
       Interestingly, murine CD4+ T cells stimulated with anti-CD3/anti-CD28 displayed a 
Th1-like cytokine profile while cells stimulated with anti-CD3/PMA displayed a Th2-
like cytokine profile (74). These data suggest that the anti-inflammatory effect of dietary 
n-3 PUFA could be due to a combination of direct suppression of Th1 responses and an 
indirect regulation through enhanced Th2 activation. To date, the effects of dietary n-3 
PUFA on individual Th subsets has not been determined. There is only very limited data 
on how FO affects Th1 and Th2 cytokine production. Wallace et al reported a decrease 
in IFN-γ production in splenocytes from FO-fed mice (75). Suppressed IFN-γ gene 
expression was detected in the Peyer’s patches of FO-fed BB rats (76). In addition, in 
human MS patients, FO supplementation resulted in reduced IFN-γ secretion by blood 
lymphocytes (77). In contrast to these studies, no effect on IFN-γ production by murine 
spleen lymphocytes was seen in mice fed a diet enriched in n-3 PUFA (78). FO 
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exhibited little effect on IL-4 secretion or gene expression in spleens from FO-fed mice 
(75). While FO feeding increased IL-10 gene expression in Peyer’s patches in BB rats 
(76), FO supplements for pregnant women resulted in decreased neonatal IL-10 
secretion (79). These conflicting results could be explained by important differences 
between the study parameters. First, different models were used. Cytokine production 
was examined in either murine splenocytes, gut-associated immune cells or human 
peripheral lymphocytes. Second, the cytokines were examined after a short period of 
stimulation. It has been shown that IL-4 expression depends on cell cycle progression 
and only increases dramatically and acquires a stable phenotype after 48 h in culture 
(80). Third, mixed cell populations were used, which means that the cytokine 
concentrations may not truly reflect the balance between Th1 and Th2 cells. In order to 
conclusively determine how dietary n-3 PUFA influence the Th1/Th2 balance, 
experiments using purified CD4+ T cells that have been classically polarized to Th1 or 
Th2 effector cells are required. 
       This laboratory has used C57BL/6 mice as a model to study the effects of dietary n-
3 PUFA on T cell function. In the past 10 yr, we have shown that dietary n-3 PUFA 
suppress mitogen stimulated splenocyte proliferation and anti-CD3/anti-CD28 
stimulated proliferation of purified CD4+ T cells (3,74,81). We have also demonstrated 
that dietary n-3 PUFA suppress surface CD3/CD28 function, modulate lipid composition 
of CD4+ T cells, in the lipid rafts and inhibit the recruitment of PKC θ to lipid rafts 
resulting in the down-regulation of AP1 and NF-κB activation (82). In addition, we have 
also shown that dietary n-3 PUFA enhanced AICD in purified CD4+ T cells and 
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polarized Th1 cells (83,84). C57BL/6 mice are Th1-prone, thus, making this strain a 
suitable choice to study the possible role of dietary n-3 PUFA on the regulation of 
Th1/Th2 differentiation. However, antigen specific T cell activation has not been 
extensively studied. Pompos et al. reported reduced proliferation and IL-2 secretion in 
OVA stimulated splenocytes from transgenic DO11.10 mice fed a FO diet (53). No 
study has examined the effect of dietary n-3 PUFA on antigen stimulated purified CD4+ 
T cells. In addition, the precise effects of dietary n-3 PUFA on antigen stimulated 
Th1/Th2 differentiation has not been studied. 
      Previous studies from our lab have shown that low dose, short-term n-3 PUFA 
feeding can modulate T cell function in C57BL/6 mice. Feeding as short as 10 d with 5% 
FO results in a significant effect on T cells (74). Because regular mouse chow contains 
low amounts of n-3 PUFA, in order to control exposure to dietary fatty acids, mice were 
placed on a control baseline CO diet (5% by weight) for 1 wk to wash out n-3 PUFA 
from T-cell membranes. Mice were subsequently fed the experimental diets for 2 wk 
containing either CO or FO. 
       The overall objective of the project was to determine the effect of dietary n-3 PUFA 
on murine Th1 and Th2 development using both C57 BL/6 mice and the DO11.10 
transgenic mice. The results of these experiments will contribute to the understanding of 
the mechanisms by which dietary n-3 PUFA modulate T cell functions and provide data 
which will support the rational application of dietary n-3 PUFA as adjunct therapy in T-
cell mediated inflammatory diseases. 
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CHAPTER II 
DIETARY n-3 POLYUNSATURATED FATTY ACIDS MODULATE MURINE 
Th1/Th2 BALANCE TOWARDS THE Th2 POLE BY SUPPRESSION OF Th1 
DEVELOPMENT* 
       We have shown that dietary long chain n-3 polyunsaturated fatty acids (PUFA) 
present in fish oil (FO) affect CD4+ T cell proliferation and cytokine production in 
C57BL/6 mice. To test the hypothesis that the anti-inflammatory effect of dietary n-3 
PUFA could be due to the indirect suppression of Th1 cells by cross-regulation of 
enhanced Th2 activation, mice were fed a wash out control diet (5% corn oil (CO), n-6 
PUFA) for 1 wk, followed by maintenance on the control diet or a fish oil diet (1% CO + 
4% FO, n-3 PUFA) for 2 wk. Splenic CD4+ T cells were cultured under both neutral and 
Th2 polarizing conditions for 2 d. Cells were reactivated and analyzed for IL-4 and 
interferon-γ production by intracellular cytokine staining. Dietary FO increased the 
percentage of Th2 polarized cells and suppressed Th1 cell frequency under neutral  
conditions. However, under Th2 polarizing conditions, while the suppression of Th1 
cells was maintained in FO-fed mice, no effect was observed in Th2 cells. Dietary FO  
__________________________________ 
*Reprinted with permission from “Dietary (n-3) polyunsaturated fatty acids modulate 
murine Th1/Th2 balance toward the Th2 pole by suppression of Th1 development” by 
Zhang, P. et al., 2005. J. Nutr. 135, 1745-1751. Copyright 2005 by American Society for 
Nutritional Sciences. 
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increased the Th2/Th1 ratio in the presence of homologous mouse serum under both 
neutral (p=0.0009) and Th2 polarizing conditions (p=0.0185). The FO diet did not 
significantly affect proliferation under Th2 polarizing conditions. Thus, the anti-
inflammatory effects of FO may be explained, in part, by a shift of the Th1/Th2 balance, 
due to the direct suppression of Th1 development, and not by enhancement of the 
propensity of CD4+ T cells to be polarized toward a Th2 phenotype, at least in vitro. 
 
INTRODUCTION 
       Two polarized CD4+ T cell subsets have been identified by their signature cytokines 
and their mutually exclusive helper functions. T-helper 1 effector (Th1) cells produce 
IL-2, IFN-γ, and lymphotoxin; T-helper 2 (Th2) cells produce IL-4, IL-5, IL-10 and IL-
13 (26). The pathogenic role of Th1 and the protective role of Th2 cells have been 
described for certain autoimmune diseases such as rheumatoid arthritis (RA), multiple 
sclerosis (MS), and insulin-dependent diabetes mellitus (IDDM) (28). In some cases, the 
Th1/Th2 balance was an important indicator of the disease state (76). A shift from Th1 
to Th2 cytokine profiles was observed in many clinical interventions that resulted in 
improvement in these diseases (85,86). Modulation of the Th1/Th2 balance has provided 
a new paradigm for immunomodulatory therapy in some autoimmune diseases (87). 
       The beneficial effects of dietary fish oil (FO) on Th1 mediated diseases have been 
well documented (5,6). The principal bioactive constituents of FO are considered to be 
EPA and DHA. Epidemiological studies showed decreased incidence of 
autoimmune/inflammatory diseases in Greenland Eskimos whose diets are rich in EPA 
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and DHA from fish (4). Clinical dietary intervention trials also showed a protective 
effect of FO in a number of Th1-mediated autoimmune diseases such as RA, Crohn’s 
disease, and ulcerative colitis (6). A shift away from a Th1 response was considered to 
be the mechanism that resulted in the benefits of FO (75).  
       The anti-inflammatory effect of n-3 PUFA in FO may be attributed, in part, to direct 
suppression of T cell function (3). FO has been shown to inhibit T cell proliferation, IL-2 
secretion, IL-2 receptor expression, and CD28 function (71,73,88). To date, the effects 
of dietary (n-3) PUFA on individual T helper cell subsets has not been determined. 
There are only very limited data on how FO affects Th1 and Th2 cytokines (78). 
Wallace et al reported decreased IFN-γ in splenocytes from FO-fed mice (75). 
Suppressed IFN-γ gene expression was found in the Peyer’s patches in FO-fed BB rats 
(76). In human MS patients, FO supplementation resulted in reduced IFN-γ secretion by 
blood lymphocytes (77). In contrast to these studies, no effect on IFN-γ production by 
murine spleen lymphocytes was seen in mice fed a diet enriched in (n-3) PUFA (78). FO 
exhibited little effect on IL-4 secretion or gene expression in spleens from FO-fed mice 
(75). While FO feeding increased IL-10 gene expression in Peyer’s patches in BB rats 
(76), FO supplements for pregnant women resulted in decreased neonatal IL-10 
secretion (79). In order to conclusively determine how dietary (n-3) PUFA influence the 
Th1/Th2 balance, experiments using purified CD4+ T cells which have been polarized 
into Th1/Th2 cells are necessary. 
       Previous data from our laboratory revealed that purified mouse CD4+ T cells from 
C57BL/6 mice stimulated with different agonists displayed different cytokine profiles, 
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corresponding to Th1-like and Th2-like cells (74). The increased proliferation of Th2-
like cells and the suppressed IL-2 secretion by Th1-like cells from FO-fed mice 
suggested that the anti-inflammatory effects of dietary n-3 PUFA may be the combined 
result of direct suppression of IL-2 induced Th1 activation and indirect suppression of 
Th1 cells through cross-regulation of enhanced Th2 activation. There is ample evidence 
that diminished Th1 responses following therapy of some Th1-mediated autoimmune 
diseases are accompanied by enhanced Th2 responses (28,76,85). Therefore, in the 
current study, we tested the hypothesis that the anti-inflammatory effects of dietary fish 
oil are due, in part, to enhanced Th2 activation. Our results indicated that dietary (n-3) 
PUFA alter the Th1/Th2 balance towards the Th2 pole by selectively suppressing Th1 
development rather than by enhancing Th2 development. 
 
MATERIALS AND METHODS 
Animals and diets  
       All experimental procedures using laboratory animals were approved by the 
University Laboratory Animal Care Committee of Texas A&M University. Pathogen-
free, female, young C57BL/6 mice (12-14 g) were purchased from Frederick National 
Cancer Research Facility, Frederick, MD. Mice were housed 5 per microisolator cage, 
and had free access to water and diet. Mice were fed a control semi-purified diet 
containing 5% corn oil (CO) during the 7-d acclimation period followed by 2 wk of 
feeding with either the same control diet or a fish oil (FO) diet (1% CO + 4% FO). The 
diets met NRC nutrition requirements and varied only in lipid content (21). The basic 
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diet composition, expressed as g/100g was: casein, 20; sucrose, 42; cornstarch, 22; 
cellulose, 6; AIN-76 mineral mix, 3.5; AIN-76 vitamin mix, 1; DL-methionine, 0.3; 
choline chloride, 0.2; Tenox 20A, 0.1; and oil, 5. The fatty acid composition of the diets, 
as determined by gas chromatography, is shown in Table 1. 
                                      
 
                                      TABLE 1 
                     Dietary fatty acid composition1,2,3 
Fatty Acids       CO                            FO 
 
14:0                                     
16:0 
16:1(n-7) 
18:0 
18:1(n-9) 
18:2(n-6) 
18:3(n-3) 
20:5(n-3) 
22:5(n-3) 
22:6(n-3) 
 
             g /100 g fatty acids 
       tr4                                  7.4 
11.9                               18.6 
   tr                                  10.2 
2.1                                  2.2 
 30.1                               13.3 
 54.1                               14.9 
1.1                                   2.0 
   tr                                    8.1 
   tr                                    1.5 
        tr                                    8.5 
 
1Mean values of two analyses. 
2Abbreviations used: CO, 5% corn oil; FO, 4% fish oil + 1% corn oil (w/w); 
3Only the major fatty acids (> 1 g/100 g) are listed. 
4Tr, trace amount (< 0.1 g/100 g). 
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Chemical compounds, cytokines and antibodies 
       Phorbol myristate acetate (PMA) was purchased from Sigma (St. Louis, MO). 
Ionomycin was purchased from Calbiochem-Novabiochem (San Diego, CA). 
Recombinant murine IL-2 was purchased from R&D Systems (Minneapolis, MN). 
Hamster anti-mouse CD3e monoclonal antibody (clone145-2C11), neutralizing rat mAb 
for murine IFN-γ (clone R4-6A2), R-Phycoerythrin (PE)-labeled anti-IL-4 (clone 
11B11) and Fluorescein isothiocyanate (FITC)-labeled anti-IFN-γ (clone XMG1.2) were 
purchased from BD PharMingen (San Diego, CA). 
 
Cell culture  
       CD4+ T cells were purified from the splenocytes of C57BL/6 mice by a negative 
selection column method which we have published (74). Cells were adjusted to 5×106 
cells/ml and cultured in 24-well plates containing 2 mL complete RPMI medium [RPMI 
1640 medium with 25 mM HEPES (Irvine Scientific, Santa Ana, CA) supplemented 
with 5% FBS, 1×105 U/L penicillin and 100 mg/L streptomycin (Irvine Scientific), 2 
mM L-glutamine, and 10 µM 2-mercaptoethanol]. To drive Th2 development, cells were 
cultured for 48 h with plate bound anti-CD3 (10 µg/mL) and PMA (0.5 ng/mL) in the 
presence of IL-4 (10 ng/mL), anti-IFN-γ (10 µg/mL) and IL-2 (20 ng/mL). For 
stimulation under neutral conditions, cells were cultured only with anti-CD3 (10 µg/mL) 
and PMA (0.5 ng/mL). Select cultures were incubated with homologous mouse serum 
(HMS) (complete RPMI 1640 with 2.5% FBS and 2.5% HMS). The HMS was collected 
according to the method described by Pompos et al. (53), and was included to preserve 
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the diet-induced changes in the lipid composition of cell membranes during the in vitro 
culture period, as we have published previously (83). 
 
Proliferation assay 
       Purified CD4+ T cells were cultured at 2×105 cells per well in 96-well round-
bottomed microtitre plates (Falcon, Becton-Dickenson, Lincoln Park, NJ). Cells were 
cultured under Th2 polarizing conditions (described above) for 48 h at 37 oC with 5% 
CO2. For the final 6 h, 1.0 µCi 3[H]-thymidine was added to the cultures. Cells were 
harvested and counted as we have previously described (74). 
 
Intracellular cytokine staining 
       Intracellular cytokine staining was quantified as we have described previously with 
modifications (83). After a 48 h incubation, live cells were separated by Lympholyte-M 
and cultured (106 cells/mL) with PMA (10 ng/mL) and Ionomycin (1 µg/mL) for 5 h at 
37 oC. GolgiStop (BD PharMingen, San Diego, CA) was added during the last 2 h of 
incubation at the concentration recommended by the manufacturer. Cells were 
subsequently collected, stained with Fc block, fixed and permeabilized for 20 min at 4 
oC in 250 µL Perm/Fix (BD PharMingen, San Diego, CA). Cells were washed in 
Perm/Wash (BD PharMingen, San Diego, CA) followed by staining with PE-labeled 
mAb to murine IL-4 and FITC-labeled mAb to murine IFN-γ. Following a final wash in 
Perm/Wash, cells were resuspended in 500 µL staining buffer (PBS with 0.05% FCS and 
0.01% sodium azide) for analysis on a FACS-Calibur flow cytometer (Becton Dickinson 
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Immunocytometry systems, San Jose, CA). In preliminary studies, isotype controls for 
the anti-IL-4-PE and anti-IFN-γ were performed. These samples stained minimally (IL-4 
<0.1%, IFN-γ <0.2%) and were similar to nonstained samples (see Appendix A-2). Thus, 
in the dietary study, isotype controls were omitted and nonstained samples were used to 
set the quadrant.  
 
Statistical analysis 
       Significance of main treatment effects was assessed using PROC GLM in SAS. The 
differences between means were analyzed for significance by Tukey’s test. A 95% level 
of probability was accepted as being statistically significant. Results are from 1-3 
separate experiments. 
 
RESULTS 
Dietary fish oil alters Th1/Th2 cytokine profiles 
       In order to determine conclusively how dietary n-3 PUFA affect Th2 polarization, 
purified splenic CD4+ T cells from FO- and CO-fed mice were cultured with anti-CD3 
and PMA in the presence of IL-4, IL-2 and anti-IFN-γ with FBS or homologous mouse 
serum (HMS). Our previous data showed that CD4+ T cells cultured with anti-CD3 and 
PMA produce both IL-4 and IFN-γ (74), therefore, we chose these stimuli as neutral 
conditions for the induction of cytokines. The immunofluorescent detection of IFN-γ and 
IL-4 by intracellular cytokine staining has proven to be the appropriate method of 
characterizing polarized Th1 and Th2 cell populations and has been validated in  
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Figure 1.  Representative fluorescence-activated cell sorting (FACS) images of cytokine profiles 
obtained by intracellular cytokine staining of polarized CD4+ T cells from C57BL/6 mice 
cultured under either neutral or Th2 polarizing conditions. Splenic CD4+ T cells were purified 
from mice fed test diets and cultured with anti-CD3 and PMA (neutral conditions) or with anti-
CD3, PMA, IL-4, anti-IFN-γ and IL-2 (Th2 polarizing conditions) for 48 h in the presence of 
homologous mouse serum (HMS). Living cells were isolated and cytokines were determined by 
intracellular cytokine staining. The number in the upper left quadrant of each dot plot represents 
the percentage of Th2 cells (IL-4+, IFN-γ-) and values in lower right quadrant of each dot plot 
represents Th1 cells (IFN-γ+, IL-4-). The isotype controls were tested in preliminary studies and 
showed no difference from unstained samples (data not shown), thus, unstained samples were 
used to set the quadrant. CO, corn oil; FO, fish oil. 
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numerous publications (80,89,90). We followed the standard published protocol for 
intracellular cytokine staining (83). Briefly, cells were reactivated for 5 h in the presence 
of a protein inhibitor, GolgiStopTM, followed by incubation with FITC- conjugated 
monoclonal antibody to IFN-γ and PE-conjugated monoclonal antibody to IL-4. Stained 
cells were analyzed by flow cytometry. Representative FACS images of cytokine 
profiles obtained by intracellular cytokine staining of polarized cells from FO- or CO-
fed mice cultured with HMS are shown in Figure 1. Th2 cells were defined as cells 
producing IL-4, but not IFN-γ, and are represented by the IL-4+, IFN-γ- population in the 
upper left quadrant of each dot plot. Th1 cells were defined as cells producing IFN-γ, but 
not IL-4, and are represented by the IFN-γ+, IL-4- cells in the lower right quadrant of 
each dot plot.  
       Using the flow cytometry data for all animals, similar to the data illustrated in 
Figure 1, the mean percentage of Th1 and Th2 cells generated under neutral and Th2-
polarizing conditions were calculated and presented in Figure 2.  Panel 2A shows the 
percentage of IL-4+, IFN-γ- Th2 cells generated after 48 h culture in the presence of 
HMS. Under neutral conditions, dietary FO significantly increased the proportion of Th2 
cells by 46% (14.9% for FO-fed mice vs. 10.2% for CO-fed mice, p=0.0049). Following 
culture under Th2 polarizing conditions, there was no difference (p > 0.05) in the 
proportion of Th2 cells between the FO (15.3%) and CO (16.2%) groups.  
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 Figure 2. Dietary FO shifts the Th1/Th2 balance by suppressing Th1 development in C57BL/6 
mice. Purified CD4+ T cells from CO- or FO-fed mice were cultured under either neutral or Th2 
polarizing conditions in the presence of homologous mouse serum (HMS) for 48 h as described 
in the Materials and Methods. Cytokine production was assessed by intracellular cytokine 
staining. Panels represent IL-4+ cell frequency (A) and IFN-γ+ cell frequency (B) and the 
Th2/Th1 ratio (C). Values identified by different letters are significantly different (p<0.05). Data 
represent means ± SEM; n = 4 replicates per diet group, and 5 mice were pooled per analysis. 
CO, corn oil; FO, fish oil. 
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       Panel 2B shows the percentage of IFN-γ+, IL-4- Th1 cells generated after 48 h 
culture in the presence of HMS. Dietary FO significantly decreased the proportion of 
Th1 cells following culture under both neutral (p=0.0053) and Th2 polarizing conditions 
(p=0.0017). Under neutral conditions, 7.6% of the CD4+ T cells were Th1 polarized in 
CO-fed mice, while 5.0% of the CD4+ T cells exhibited a Th1 phenotype in FO-fed 
mice. Similarly, under Th2 conditions, 7.3% of the CD4+ T cells were Th1 polarized in 
CO-fed mice, compared to 3.9% in FO-fed mice. Thus, dietary FO suppressed Th1 cell 
development following culture under both neutral and Th2  polarizing conditions in the 
presence of HMS.  
      Panel 2C shows the ratio of Th2/Th1 cells after 48 h culture in the presence of HMS. 
Dietary FO significantly increased the ratio following culture under both neutral 
(p=0.0009) and Th2 polarizing conditions (p=0.0185). This indicates a clear shift in the 
Th1/Th2 balance towards a Th2 response in mice fed FO.  
       Figure 3 shows the percentage of IL-4+, IFN-γ- Th2 cells and IFN-γ+, IL-4- Th1 
cells after 48 h culture under Th2 polarizing conditions in the presence of FBS. Without 
HMS, there was no difference in the Th1 and Th2 cell frequency between FO- and CO- 
fed mice. Similar percentages of Th2 cells (9.4% for FO, 9.0% for CO, p>0.05, Fig. 3A) 
and Th1 cells (6.4% for FO, 6.5% for CO, p>0.05, Fig. 3B) were generated. Likewise, 
there was no difference (p>0.05) in the Th2/Th1 ratio of CD4+ T cells from mice fed FO 
(1.5) and CO (1.3) when HMS was not present in the cultures. 
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Figure 3. Dietary FO does not affect Th2 or Th1 cell frequency under Th2 polarizing conditions 
in the presence of FBS in C57BL/6 mice. Splenic CD4+ T cells were isolated from CO- or FO-
fed mice and polarized to Th2 cells in presence of FBS as described in the Materials and 
Methods. Cytokines were determined by intracellular cytokine staining. Data represent the mean 
± SEM; n = 3 replicates per diet group, and 5 mice were pooled per analysis. The experiments  
were repeated three times. A representative experiment is shown. Panel A represent IL-4+ Th2 
cells; Panel B represent IFN-γ+ Th1 cells. CO, corn oil; FO, fish oil.   
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Figure 4. Lack of effect of dietary FO on proliferation of CD4+ T cells under Th2 polarizing 
conditions. Splenic CD4+ T cells were isolated from CO- or FO-fed mice and cultured under Th2 
polarizing conditions for 48 h in presence with either FBS (Panel A) or homologous mouse 
serum (HMS) (Panel B). Cell proliferation was measured by uptake of 3H-Thymidine during the 
last 6 h of culture. Values represent the means ± SEM of net thymidine uptake (DPM) (n = 4 for 
HMS, n = 3 for FBS). Results are from 1-3 separate experiments. 
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       Dietary fish oil does not affect proliferation under Th2 polarizing conditions.  
Previously, we have shown that dietary n-3 PUFA enhance proliferation of Th2- like 
cells (74). To extend this observation, we measured the proliferation of purified splenic 
CD4+ T cells following culture under Th2 polarizing conditions in the presence of either 
FBS or HMS. The proliferative response to anti-CD3/PMA of cells from FO- and CO-
fed mice is shown in Figure 4. There was no significant difference in the degree of  
[3H]-thymidine uptake between the FO and CO cells cultured either in the presence of 
FBS (Fig. 4A) or HMS (Fig. 4B). The overall proliferation was somewhat lower in the 
presence of HMS compared with FBS in both diet groups.  
 
DISCUSSION 
      The work from our lab in the past ten years has demonstrated clearly that the anti-
inflammatory effects of dietary fish oil was due, at least in part, to suppression of various 
T cell functions in C57BL/6 mice (64,73,74,82-84,88). Recently, we showed that CD4+ 
T cells stimulated in vitro with anti-CD3/anti-CD28 displayed a Th1-like cytokine 
profile whereas those stimulated with anti-CD3/PMA showed a Th2-like cytokine 
profile (74). The observation that dietary FO suppressed IL-2 secretion of Th1-like cells 
and enhanced proliferation of Th2-like cells suggested that the anti-inflammatory effect 
of dietary n-3 PUFA could be the combined result of direct suppression of Th1 
activation and indirect suppression of Th1 response by enhanced Th2 cross-regulation 
(74). Therefore, the main purpose of this study was to test the hypothesis that the anti-
inflammatory effect of dietary n-3 PUFA was due to indirect Th1 suppression by 
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enhanced Th2 activation. We polarized murine splenic CD4+ T cells to Th2 cells in vitro 
using the same polarizing conditions as those reported by many investigators to study 
Th1/Th2 responses (55,91). The cytokines chosen for our study are among the strongest 
determinants of T cell differentiation. IL-4 induces Th2 development and reduces the 
Th1 response (27).  IL-2 is also important for Th2 development (92). The common 
polarizing protocol employs anti-CD3/anti-CD28, or PMA/Ionomycin as the stimuli, 
plus rIL-2, rIL-4 and anti-IFN-γ for 2 or 3 d. The cells are then expanded for another 3 d 
(89,90,93). An incubation period of 48 h has also been reported to be sufficient for naïve 
CD4+ T cells to acquire the Th2 phenotype in vitro (87). Since we have shown that anti-
CD3/PMA promoted Th2 cytokine production (74) we chose these stimuli plus rIL-2, 
rIL-4 and anti-IFN-γ for Th2 polarization. The dietary effect of n-3 PUFA depends, at 
least in part, on diet-induced changes in membrane lipid composition, and long-term 
culture in fetal bovine serum resulted in loss of effect of dietary PUFA on T cell function 
(83). Therefore, we incorporated HMS and contracted the culture period. Among several 
polarizing protocols tested, we found that incubation with anti-CD3/PMA plus rIL-2, 
rIL-4, and anti-IFN-γ for 48 h gave the highest proportion of IL-4 positive cells. 
Expanding the culture for another 3 d did not increase the percentage of IL-4 positive 
CD4+ T cells (data not shown). We have elected not to include data on the mean 
fluorescence intensity (MFI) of the IL-4 and IFN-γ positive cells for two reasons.  First, 
the question we addressed in this paper relates to the effect of dietary fish oil on Th2 
development in vitro. Therefore, we determined the percentage of IL-4 and IFN-γ 
positive cells which represent the Th2 and Th1 cell phenotype, respectively. Second, 
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most papers examining Th1/Th2 development only report the percentage of positive 
cells (89,90). Although the intracellular cytokine staining method provides information 
on cytokine synthesis at the single cell level, these data are relatively qualitative in 
nature. Therefore, we elected not to compare the cytokine level on per cell basis. 
      In vitro Th2 polarization is always more difficult than Th1 polarization. The majority 
of CD4+ T cells do not polarize under Th2 polarizing conditions regardless of 
background of mice or the culture conditions (80). Genetic background is one 
determinant of Th1/Th2 development (30) and C57BL/6 mice are known to be Th1-
prone (55). This may explain why less than 20% of the total cell population in our study 
was classified as IL-4+, IFN-γ- under Th2 polarizing conditions, and a small proportion 
of Th1 cells was also generated. Although repeated in vitro stimulation also seems to 
help enhance the yield of Th2 cells, IL-4 producing cells were always detected at lower 
frequency in established Th2 clones or short term Th2 polarized CD4+ T cells perhaps 
due to transient IL-4 synthesis (80). The proportion of Th2 cells generated in our culture 
was within the typical range found in the literature and comparable to reported IL-4 
positive cells under Th2 polarizing conditions from mice of similar background (94). For 
example, naïve CD4+ T cells from C57BL/6 mice cultured with anti-CD3 and anti-
CD28, in the presence of similar concentrations of IL-4, anti-IFN-γ and IL-2 for 1 wk, 
resulted in 34% Th2 cells (93). Only 9% Th2 cells were generated following stimulation 
with the Ac1-11 peptide from myelin basic protein (MBP) together with twice the IL-4 
and similar anti-IFN-γ concentrations in splenocytes from Th1-prone B10.PL MBP TCR 
transgenic mice (94). In transgenic DO11.10 mice on the Th2-prone BALB/c 
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background, only 14% Th2 cells were induced when naïve CD4+ T cells were stimulated 
with OVA peptide and antigen-presenting cells in the presence of IL-4 for 1 wk (80). 
Even in established Th2 clones, synthesis of intracellular IL-4 could only be detected in 
approximately 40% of cells (80).  
      The success of Th2 polarization was manifested by an increased Th2/Th1 ratio 
compared with culture under neutral conditions for CD4+ T cells from mice fed both 
diets. In the FO group, there was a modest increase in the absolute frequency of IL-4 
producing Th2 cells and a small decrease in IFN-γ producing Th1 cells under Th2 
polarizing conditions compared with neutral conditions. The changes resulted in a 33% 
increase in the Th2/Th1 ratio. With respect to the CO group, the increase of Th2 cells 
was more pronounced under Th2 polarizing conditions, with little change in the number 
of Th1 cells. This resulted in a significant 66% increase (p = 0.035) in the Th2/Th1 ratio 
in FO-fed mice (Fig. 2C). 
      We have demonstrated that dietary n-3 PUFA do not affect either in vitro Th2 
development or proliferation under Th2 polarizing conditions. However, dietary n-3 
PUFA did increase the Th2/Th1 ratio by suppression of Th1 development in the 
presence of HMS. Splenic CD4+ T cells from FO-fed mice exhibited decreased Th1 
differentiation following culture under both neutral and Th2 polarizing conditions (Fig. 
2B). Under neutral conditions, the simultaneous suppression of Th1 cells and 
enhancement of Th2 cells in FO-fed mice could be explained by the cross-regulation of 
Th1 and Th2 cells (95). It is possible that FO acts on Th1 cells, or Th2 cells, or both. 
Under Th2 conditions, although FO maintained the suppression of Th1 development, 
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there was no difference in Th2 differentiation between FO and CO. Because cross-
regulation of Th2 cells by Th1 cells was diminished in the presence of Th2 polarizing 
conditions, i.e., IL-4 and anti-IFN-γ, the cells were pushed toward the Th2 pole to their 
maximum capacity. The similarity in the number of Th2 cells between FO and CO under 
polarizing conditions suggests the lack of a direct effect on Th2 development (Fig. 2A). 
Therefore, dietary n-3 PUFA does not appear to enhance Th2 polarization but does 
suppress Th1 cells, thus creating a shift in the Th1/Th2 balance (Fig. 2C).  
      Our findings confirm the observation of decreased IFN-γ production by T cells from 
animals fed diets enriched with FO or human patients taking FO supplements. Fish oil 
feeding inhibited Con A stimulated IFN-γ production by whole splenocytes in C57BL/6 
mice but had little effect on Con A stimulated IL-4 production (75). Similar findings on 
IL-4 were observed in MF1 mice (78). In addition, fish oil supplements decreased IFN-γ 
production and IL-2 production by peripheral blood mononuclear cells harvested from 
MS patients (77). Previously we showed that there was no difference in IL-4 secretion in 
CD4+ T cells cultured with anti-CD3/PMA (74). Here, we show that dietary FO shifts 
the Th1/Th2 balance towards the Th2 pole by direct suppression of Th1 development, as 
evidenced by reduced IFN-γ production (Fig. 2B and 2C).  
      Suppression by dietary n-3 PUFA of Th1 development in CD4+ T cells cultured 
under Th2 polarizing conditions was only observed when T cells were cultured in the 
presence of HMS (Fig. 2B). When the cells were polarized in cultures with FBS, there 
was no difference in either Th2 or Th1 development from CD4+ T cells from FO- and 
CO-fed mice (Fig. 3). The suppression of Th1 cells by FO feeding could be due to 
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changes in lipid rafts. Our lab has demonstrated that FO feeding modulates the lipid 
composition of raft microdomains in murine CD4+ T lymphocytes (64). HMS in culture 
has been shown in our experimental system to be essential to preserve the diet-induced 
in vivo changes in T cell function and microdomain lipid composition (83). Considering 
that activated Th1 and Th2 cells have distinct patterns of membrane receptor 
compartmentalization into lipid rafts (45), it is possible that dietary n-3 PUFA 
differentially modulate membrane microdomains in Th1 and Th2 cells and selectively 
inhibit recruitment of certain signaling molecules important for Th1 differentiation and 
activation. In support of this hypothesis, we have shown that dietary DHA inhibits 
recruitment of PKC-θ into lipid rafts in CD4+ T cells stimulated with anti-CD3 and anti-
CD28, resulting in reduced NF-κB and AP-1 activation and IL-2 secretion (82). 
Differentiation of CD4+ T cells into Th1 cells requires the activation of a MAP kinase, 
JNK2, while differentiation into Th2 cells does not require JNK2 activation (96). In 
addition, NFAT promotes Th1 differentiation (97). Treatment of human Jurkat cells with 
EPA significantly inhibited JNK activity and NFAT (98). This may also occur in FO-fed 
mice, and explain why dietary FO only affects Th1 differentiation. The selective 
inhibition of JNK and NFAT could be explained by modulation of rafts by PUFA. The 
translocation of the palmitoylated and acylated adapter protein, LAT, has been shown to 
be an important upstream event for NFAT activation (61). Treatment of human Jurkat 
cells with EPA resulted in the displacement of LAT from rafts (63). It is therefore 
possible that alteration in lipid raft composition could regulate JNK activation. Taken 
together, the data suggest that the suppression of Th1 development by FO feeding could 
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be due to changes in the molecular interactions of lipids in rafts. These hypothetical 
mechanisms will be tested in future experiments. 
      The lower proliferation of Th2-polarized CD4+ T cells observed in the presence of 
HMS but not FBS (Fig. 4), is consistent with previous findings (53). We have previously 
observed enhanced proliferation in Th2-like CD4+ T cells from FO-fed mice (74), which 
was not recapitulated in this study. This may be attributable to differences in stimuli and 
culture conditions. Since a heterogeneous CD4+ T cell population (Th1, Th2, and 
unpolarized) existed in the present studies, the proliferation measured represented the 
sum of all cells present. Only experiments using an isolated Th2 population will provide 
a definitive conclusion about the precise effect of diet on Th2 proliferation. These results 
differ from the well-documented suppression of lymphocyte proliferation by FO 
observed by us and others (71,73). However, considering that FO only affected Th1 
development, it is possible that the reported suppression of lymphocyte proliferation was 
observed in cell cultures where Th1 cells dominated.  
      In summary, we found that dietary n-3 PUFA shift the Th1/Th2 balance towards the 
Th2 pole by suppression of Th1 development rather than enhancement of Th2 
development. The results here are directly relevant to the therapeutic use of dietary FO 
in many Th1-mediated autoimmune and hypersensitivity diseases. Fish oil has the 
capacity to suppress Th1 development and reduce IFN-γ production without a 
concomitant effect on Th2 development. This may be beneficial because n-3 PUFA will 
not affect Th2-related antibody production, which may be important for resistance 
against some infections (28). Although Th2 cells were initially thought to be protective 
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in some autoimmune diseases, subsequent research showed that a deviation in the Th1 to 
Th2 effector population might result in more complications in many Th1-mediated 
diseases (99-101). Therefore, the lack of a direct effect on Th2 cells has advantages for 
FO as an adjunct therapy for Th1-mediated autoimmune diseases. 
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CHAPTER III 
DIETARY N-3 POLYUNSATURATED FATTY ACIDS INHIBIT ANTIGEN-
SPECIFIC Th1 CELL DEVELOPMENT BY SUPPRESSION OF CLONAL 
EXPANSION 
       Dietary fish oil (FO) supplementation has been shown to be beneficial in certain 
Th1-mediated autoimmune diseases. The purpose of this study was to determine how 
dietary FO affects antigen-stimulated Th1 cell development in vitro. DO11.10 Rag2-/- 
TCR-transgenic mice were fed a control diet (5% corn oil (CO), n-6 PUFA) for 1 week, 
followed by the same control diet or a FO diet (1% CO + 4% FO, n-3 PUFA) for 2 wk. 
CD4+ T cells were isolated from spleens and lymph nodes, stimulated with OVA peptide 
and irradiated BALB/c splenocytes in the presence of rIL-12, αIL-4, and rIL-2 for 2 d, 
followed by expansion with rIL-2 and rIL-12 for 3 d. After reactivation with PMA and 
Ionomycin, cells were surface stained with the clonotypic mAb KJ1-26, followed by 
intracellular staining for IFN-γ and IL-4. Flow cytometric analysis showed no difference 
(p>0.05) in the percentage of KJ1-26+, IFN-γ+, IL-4- Th1 cells between CO-fed 
(98.8±0.7%) and FO-fed mice (97.4±0.8%). However, the absolute number of Th1 cells 
in polarized cultures from FO-fed mice was 61% lower than that observed in CO-fed 
mice (p=0.03). Cell proliferation, as assayed by 3H-thymidine uptake, showed a 15% 
decrease in Th1 cells from the FO group (p=0.01). Therefore, an attenuated Th1 
response in clinical trials of FO supplementation may be explained, at least in part, by 
suppression of clonal expansion during Th1 differentiation. 
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INTRODUCTION 
      Antigen stimulation elicits clonal expansion of CD4+ T cells, during which, the cells 
may differentiate into two distinct types of effector cells, Th1 and Th2, based on 
cytokine secretion profiles. Th1 cells produce IL-2, IFN-γ, and lymphotoxin; Th2 cells 
produce IL-4, IL-5, IL-10 and IL-13 (26,102). Although there is controversy regarding 
the role of Th2 cells in some autoimune diseases such as insulin-dependent diabetes 
mellitus (IDDM), multiple sclerosis (MS), the pathogenic role of Th1 cells in such 
diseases is well established (28,99). Elucidation of the molecular basis for Th1 and Th2 
development could contribute to the modulation of Th1/Th2 ratios as therapy for treating 
Th1 cell- mediated chronic inflammation (40,41,90). Cytokines play crucial roles in 
mediating the Th cell differentiation outcome. For example, IL-12 promotes Th1 
development, while IL-4 favors Th2 development (55). Many other factors have been 
found to influence Th1/Th2 differentiation: genetic background, antigen dose, and the 
strength of TCR and costimulatory signaling (27,30,33). Interestingly, some nutrients 
such as Vitamins A, D, E, and dietary component ribonucleotides have also been shown 
to strongly influence Th1/Th2 differentiation (36-39,94). Therefore, defining the 
mechanisms by which nutrients modulate Th1/Th2 development could facilitate the use 
of diet as adjunct therapy for treating T cell-mediated autoimmune diseases.  
      Among dietary factors, n-3 polyunsaturated fatty acids (PUFA) found in fish oil (FO) 
have been shown to attenuate many T cell-mediated inflammatory diseases (6,103). The 
primary effector molecules are considered to be eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA). Clinical dietary intervention trials demonstrated a 
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protective effect of FO in rheumatoid arthritis (RA), Chrohn’s disease, and ulcerative 
colitis (5). Dietary FO has also been shown to have beneficial effects in various animal 
models of human chronic diseases, including decreased joint inflammation in rodents 
with collagen-induced arthritis, reduced inflammation in rat models of colitis, and 
decreased proteinuria in mice with autoimmune glomerulonephritis (5).  
      We and others have recently demonstrated that dietary n-3 PUFA affect a variety of 
immune responses by modulating T cell function (6). Specifically, FO suppressed 
proliferation of splenocytes and purified CD4+ T cells in response to mitogen, reduced 
IL-2 secretion and IL-2 receptor mRNA, increased AICD of CD4+ T cells and polarized 
Th1 cells, and suppressed T cell signaling, in part via changes in lipid rafts. 
(64,73,74,82,84). However, studies investigating the effects of dietary n-3 PUFA on Th1 
and Th2 effector cells and their cytokines are limited. Wallace et al reported decreased 
IFN-γ protein in splenocytes from FO-fed mice (75). Suppressed IFN-γ gene expression 
was also found in the Peyer’s patches of FO-fed BB rats (76). Similarly, in human MS 
patients, FO supplementation reduced IL-2 and IFN-γ secretion by peripheral blood 
mononuclear cells (77). In addition, FO supplementation of healthy human volunteers 
decreased DTH responses to seven recall antigens (6). It is known that the DTH 
responses are mediated by Th1 subsets (104).  Consistent with these human studies, FO-
fed mice showed reduced DTH responses when compared to those fed the control n-6 
PUFA or olive oil-rich diets (105). Taken together, these studies strongly suggest that 
FO may suppress the immune response by inhibiting proinflammatory cytokine 
production by Th1 cells. 
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      Our laboratory recently demonstrated that purified mouse CD4+ T cells stimulated in 
vitro with various agonist combinations display distinct cytokine profiles that correspond 
with Th1 and Th2 cells (74). Splenic CD4+ T cells cultured with phorbol ester (PMA) 
and Ionomycin expressed a Th1-like cytokine profile while those activated with anti-
CD3/PMA exhibited a Th2-like profile. The suppressed IL-2 secretion of Th1-like cells 
from FO-mice compared to CO-fed mice suggested that FO may alter Th1 development. 
Indeed, we recently confirmed that the anti-inflammatory properties of dietary FO were 
due, in part, to a direct effect on Th1 development as opposed to the indirect regulation 
of Th2 activation (106). Unfortunately, to date, previous studies of n-3 PUFA on T cell 
function have used non-physiologic, polyclonal stimuli such as ConA or anti-
CD3/CD28. In addition, little is known regarding how dietary n-3 PUFA affect antigen-
induced T cell activation and antigen-stimulated Th1 development. Therefore, in the 
current study, we investigated the effects of dietary n-3 PUFA on antigen-specific CD4+ 
T cell activation and differentiation into Th1 cells in vitro using the DO11.10 Rag2-/- 
transgenic mouse system, a widely used model to study antigen-specific T cell activation 
and differentiation. The DO11.10 mouse expresses a transgenic T cell receptor (TCR), 
which recognizes a peptide, OVA 323-339, within ovalbumin and can be identified by 
using the clonotypic mAb KJ1-26 (54). Besides antigen-specificity, this model has 
another advantage due to the rag 2 gene deletion. Virtually all peripheral CD4+ T cells 
from these mice are TCR transgenic, whereas only about 25% of the CD4+ T cells 
express the transgenic TCR in the periphery of the conventional DO11.10 mouse. Using 
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this model, we report that dietary n-3 PUFA inhibits antigen-specific CD4+ T cell 
proliferation and clonal expansion of polarized Th1 cells. 
 
MATERIALS AND METHODS 
Animals and diets 
       All experimental procedures using laboratory animals were approved by the 
University Laboratory Animal Care Committee of Texas A&M University. Pathogen-
free, female, young BALB/c (4-6 wk of age) were purchased from Frederick National 
Cancer Research Facility, Frederick, MD. DO11.10 Rag2-/- mice were purchased from 
Taconic, bred and maintained at Texas A & M University. At the onset of the study, 
DO11.10 Rag2-/- mice (8-10 wk) were housed 5 per microisolator cage, and had free 
access to water and diet. DO11.10 Rag2-/- mice were fed a control semi-purified diet 
containing 5% corn oil (CO) by weight during the 7-d acclimation period followed by a 
2-wk feeding period with the same control diet or a fish oil (FO) diet (1% CO + 4% FO). 
All diets met the NRC nutrition requirements and varied only in lipid content (84). The 
basic diet composition, expressed as g/100g was: casein, 20; sucrose, 42; cornstarch, 22; 
cellulose, 6; AIN-76 mineral mix, 3.5; AIN-76 vitamin mix, 1; DL-methionine, 0.3; 
choline chloride, 0.2; Tenox 20A, 0.1; and oil, 5. The fatty acid composition of the diets, 
as determined by gas chromatography, is shown in Table 1. BALB/c mice were fed 
standard mouse chow. 
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Chemical compounds, cytokines and antibodies 
       Phorbol myristate acetate (PMA) was purchased from Sigma (St. Louis, MO). 
Ionomycin was purchased from Calbiochem-Novabiochem (San Diego, CA). 
Recombinant murine IL-2 was purchased from R&D Systems (Minneapolis, MN). 
Neutralizing rat mAb for murine IL-4 was obtained from the National Cancer Institute. 
Hamster anti-mouse CD3e monoclonal antibody (clone145-2C11), recombinant murine 
IL-12, PE-labeled anti-IL-4 (clone 11B11) and FITC-labeled anti-IFN-γ (clone 
XMG1.2) was purchased from BD PharMingen (San Diego, CA). OVA323-339 peptide 
was synthesized by Biosource, International, Camrillo, CA using the following 
sequence: ISQAVHAAHAEINEAGR. Mouse monclonal antibody to DO11.10 TCR 
KJ1-26 was purchased from Caltag Laboratories, Burlingame, CA. 
 
T cells 
       Spleens and lymph nodes (brachial and mesenteric) were taken from DO11.10  
Rag2-/- mice and placed in 3 mL RPMI complete media (RPMI 1640 medium with 25 
mM HEPES (Irvine Scientific, Santa Ana, CA) supplemented with 5% FBS or 
homologous mouse serum (HMS), 1×105 U/L penicillin and 100 mg/L streptomycin 
(Irvine Scientific), 2 mM L-glutamine, and 10 µM 2-mercaptoethanol). The spleens and 
lymph nodes were homogenized and filtered as described earlier (74). Cells were then 
combined and total lymphocytes enriched by density gradient centrifugation using 
Lympholyte-M (Cedarlane, Toronto, Canada). CD4+ T cells were purified by a negative 
selection column method as previously described (74). For Th1 polarization, cells were 
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adjusted to 2.5×105 cells/mL and cultured in 24-well plates in 2 mL complete media, 
with 5x106 irradiated BALB/c splenoctyes. Homologous serum was collected according 
to the method of Pompos et al. (53). 
 
Th1 polarization 
       To drive Th1 development, CD4+ T cells were cultured with the OVA peptide (0.3 
µM) in the presence of irradiated BALB/c splenocytes (2600 rads) combined with rIL-12 
(5 ng/mL), anti-IL-4 (10 µg/mL) and rIL-2 (20 ng/mL). After culture at 37 oC with 5% 
CO2  for two days, the cells were expanded with 20 ng/mL rIL-2 and 5 ng/mL rIL-12 for 
an additional three days. Cytokine expression was analyzed via Flow cytometry 
(FACScan; Becton Dickinson, Bedford, MA).  
 
Intracellular cytokine staining 
       Following Th1 polarization, live cells were separated by Lympholyte-M and 
cultured (106 cells/mL) with PMA (10 ng/mL) and Ionomycin (1µg/mL) for 5 h at 37 oC. 
A protein transport inhibitor, GolgiStopTM (BD Farmington, San Diego, CA), was added 
according to the manufacturer’s recommendations during the last 2 h of incubation. Cells 
were subsequently isolated by centrifugation, stained with Fc block, washed and stained 
with KJ1-26-TC (Caltag laboratories, Burlingame, CA). After fixation and 
permeabilization steps for 20 min at 4 oC in 250 µl Perm/Fix (BD Farmington, San 
Diego, CA), cells were washed in Perm/Wash (BD PharMingen, San Diego, CA) twice 
followed by staining with PE-labeled mAb to murine IL-4 and FITC-labeled mAb to 
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murine IFN-γ in 100 µL Perm/Wash. The cells were washed twice in Perm/Wash and 
resuspended in 500 µL staining buffer (PBS with 0.05% FBS and 0.01% sodium azide) 
for analysis on a FACS-Calibur (Becton Dickinson Immunocytometry systems, San 
Jose, CA).  
       
T cell proliferation 
       For proliferation of CD4+ T cells under neutral conditions, CD4+ T cells were 
cultured with OVA peptide (0.3 µM) in the presence of irradiated BALB/c splenocytes 
(2600 rads) in 96-well round-bottomed microtitre plates (Falcon, Becton-Dickinson, 
Lincoln Park, NJ). Cells were labeled with 1.0 µCi [3H]thymidine and cultured for 5 h at 
37 oC with 5% CO2. Cells were harvested and counted as described previously (74). For 
proliferation of polarized Th1 cells, following Th1 polarization, cells were resuspended 
and a 200 µL aliquot was transferred to 96-well round-bottomed microtitre plates 
(Falcon, Becton-Dickinson, Lincoln Park, NJ). Cell proliferation was measured as 
described above. 
 
IL-2 receptor assay  
       CD4+ T cells from diet-fed DO11.0 Rag2-/- mice were cultured with OVA peptide 
(0.3 µM) in the presence irradiated BALB/c splenocytes (2600 rads) for 24 h. For 
quantitative surface IL-2 receptor staining, 1x106 cells were stained with vital dye 7-
amino-actinomycin D (7-AAD) and anti-CD25-PE (BD PharMingen). Quantification 
was performed using PE-labeled beads (Becton-Dickinson) (details see Appendix B-12). 
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Apoptosis 
       CD4+ T cells from diet-fed DO11.0 Rag2-/- mice were Th1 polarized as described 
above. Cells were harvested and stained with Annexin-V and PI (BD PharMingen) and 
analyzed by flow cytometry as previously described (84) (details see Appendix B-13).  
 
Statistical analysis 
       Significance of main treatment effects was assessed using PROC GLM in SAS. The 
differences between means were determined by Tukey’s test. A 95% level of probability 
was accepted as being statistically significant. 
 
RESULTS 
Lymphocyte yield from DO11.10 Rag 2-/- mice 
      Spleens from DO11.10 Rag2-/- mice were much smaller than spleens from B10.D2 
wild type mice. Total splenic lymphocyte yield (1.7 x 106) was much lower than that in 
the wild type mice (20-30 x 106). Approximately 40-70% of the cells was TCR positive 
in whole blood from the transgenic mice, while greater than 90% cells from lymph nodes 
were CD4+ and TCR+ (Appendix A-3).  
 
Dietary n-3 PUFA suppress antigen specific CD4+ T cell proliferation 
      To determine how dietary n-3 PUFA affect antigen specific CD4+ T cell 
proliferation, CD4+ T cells from CO and FO-fed DO11.10 Rag2-/- mice were isolated 
and stimulated with OVA peptide in the presence of irradiated splenocytes from chow- 
 57
 
 
Figure 5. Dietary FO suppresses antigen-specific CD4+ T cell proliferation. Purified CD4+ T cells from 
DO11.10 Rag2-/- mice were cultured with OVA peptide and irradiated BALB/c splenocytes in 96-well 
plates in the presence of either FBS or homologous mouse serum (HMS). The cells were labeled with 
[3H]Thymidine for the last 5 h of the 72 h incubation. Values represent the mean ± SEM of the net 
thymidine uptake (DPM); n=4 replicates per diet group, and 5 mice were pooled per analysis. Different 
letters indicate significant differences between the two diet groups. 
 
fed BALB/c mice. Preliminary studies demonstrated that CD4+ T cells from DO11.10 
Rag2-/- mice proliferate in a manner dependent both on the dose of OVA peptide and the 
number of antigen-presenting cells (APCs) (Appendix A-5). The optimum OVA dose 
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was in the range of 0.1-1 µM and two concentrations of APC were selected to examine 
optimal and suboptimal stimulation of CD4+ T cells. When cultured in the presence of  
homologous mouse serum, FO significantly suppressed [3H]thymidine incorporation at 
two APC concentrations (Fig. 5). However, when cultured with FBS, there was no 
significant difference in T-cell proliferation under either optimal or suboptimal 
conditions from CO and FO-fed mice (p > 0.05).  
 
Dietary n-3 PUFA do not affect in vitro Th1 differentiation 
      To determine whether dietary n-3 PUFA affect in vitro antigen-stimulated Th1 
differentiation, CD4+ T cells harvested from CO and FO-fed DO11.10 Rag2-/- mice were 
stimulated with OVA peptide in the presence of irradiated splenocytes from chow-fed 
BALB/c mice and rIL-12, rIL-2, and anti-IL-4. The cytokine patterns of differentiated 
Th1 cells were very similar for CO and FO-fed mice. Virtually all cells were IFN-γ 
positive, IL-4 negative Th1 cells following the 5-d in vitro polarization regimen, FO 
(97%) and CO (99%) (Fig. 6). Only Th1 cells were generated and no Th2 
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Figure 6. Dietary FO does not affect antigen-specific Th1 differentiation. Purified CD4+ T cells 
from DO11.10 Rag2-/- mice (different than Fig. 5) were cultured with OVA peptide in the presence 
of irradiated BALB/c splenocytes with IL-12, IL-2, and anti-IL-4. After 2 d, the cell culture was 
expanded for another 3 d. At d 5, cells were harvested, restimulated for 5 h with 
PMA/Ionomycin for intracellular IFN-γ and IL-4 staining. A: Representative dot plots from 
cultures from FO and CO-fed mice. The numbers in the lower right quadrant of the dot plot are 
the percentage of IFN-γ-producing cells (Th1) and the numbers in the upper left quadrant are the 
percentage of IL-4-producing cells (Th2). B: Bars represented the percentage of Th1 cells 
generated under above conditions. Data represent means ± SEM; n=4 replicates per diet group, 
and 5 mice were pooled per analysis. 
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Figure 7. Dietary FO suppresses IL-2 induced clonal expansion of Th1 cells. Purified 
CD4+ T cells from DO11.10 Rag2-/- mice (same as Fig.6) were cultured with OVA 
peptide in the presence of irradiated BALB/c splenocytes with IL-12, IL-2, anti-IL-4. 
After 2 d, the cell culture was expanded for another 3 d. At d 5, cells were harvested, 
viable cells separated by Lympholyte-M, and the number of living cells was determined 
by trypan blue exclusion using a hemocytometer. Letters indicate significant differences 
between the two diet groups. Data represent means ± SEM; n=4 replicates per diet 
group, and 5 mice were pooled per analysis. 
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cells were detected. These data indicated that FO feeding did not influence in vitro Th1 
differentiation. 
 
Dietary n-3 PUFA suppress IL-2 induced clonal expansion of antigen-specific Th1 
cells  
       Although dietary FO did not affect Th1 differentiation, a difference in media color 
was noticed between cultures of cells from FO and CO-fed mice. The color of cultures 
from CO-fed mice was yellowish by d 5 but the color of FO was still pink.  
      This suggests that the dynamics of cell growth were different between the two 
groups during the last 3-d expansion period. Analysis of cell counts showed a significant 
difference between FO and CO cultures (p=0.0335, Fig. 7). The absolute total number of 
viable cells harvested from FO-fed mice cultures (1.5 x 106 cells per well) was 61% 
lower than that from CO-fed mice (3.7 x 106 cells per well). These data indicate that FO 
feeding suppressed IL-2 induced clonal expansion of differentiated Th1 cells. In 
addition, with regard to [3H]thymidine incorporation, the proliferative response was 
significantly decreased at d 4 (p=0.042) and d 5 (p=0.0115, Fig. 8).  
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Figure 8. Dietary FO suppresses IL-2 induced cell proliferation of polarized Th1 cells. 
Purified CD4+ T cells from DO11.10 Rag2-/- mice (different from Fig. 7) were cultured 
with OVA peptide in presence of irradiated BALB/c splenocytes with IL-12, IL-2, anti-
IL-4. After 2 d, the cell culture was expanded for another 3 d. At d 4 and 5, cells were 
transferred to 96-well plates and labeled with [3H]thymidine for 5 h. Values represent 
the mean ± SEM of the net thymidine uptake (DPM); n=4 replicates per diet group, and 
5 mice were pooled per analysis. Different letters indicate significant differences 
between the two diet groups. 
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Figure 9. Dietary FO does not affect early apoptosis in IL-2 expanded Th1 effector cells. Purified CD4+ T 
cells from DO11.10 Rag2-/- mice (different from Fig. 8) were cultured with OVA peptide in presence of 
irradiated BALB/c splenocytes with IL-12, IL-2, anti-IL-4. After two days, the cell culture was expanded 
for another three days. At day 4 and 5, cells were harvested and live cells separated by Lympholyte-M. 
Cells were stained with Annexin-V-FITC and propidium iodide and analyzed by flow cytometry. Data 
represent means ± SEM; n=4 replicates per diet group, and 5 mice were pooled per analysis. 
 
 
 
Dietary n-3 PUFA does not affect apoptosis of polarized Th1 cells 
      To determine whether apoptosis contributed to decreased cell number in Th1 
polarized cultures from FO-fed mice, Th1 cells were stained using Annexin-V-FITC and 
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PI. Flow cytometric analysis revealed no difference in early apoptosis (Annexin-V 
positive and PI negative cells) between FO and CO-fed mice at day 4 and day 5 in 
culture (Fig. 9). 
 
Surface CD25 expression on antigen-specific CD4+ T cells is not altered by diet 
      To further elucidate the influence of dietary n-3 PUFA on IL-2 induced proliferation 
of polarized Th1 cells, surface CD25 expression was determined on CD4+ T cells from 
diet fed mice stimulated with OVA. As expected, stimulation with OVA increased 
surface CD25 expression compared to non-stimulated cells (Fig. 10 A). Since the same 
amount of IL-2 was present in the Th1 polarizing cultures during the last three days 
expansion period, the decreased proliferation could be explained by a suppression of IL-
2 receptor signaling. It is known that the polarizing conditions did not alter cell 
proliferation in similar cultures of antigen-specific CD4+ T cells (48). Indeed, we also 
observed decreased proliferation of CD4+ T cells under non-polarizing conditions. 
Therefore, we decided to measure IL-2 R α chain (CD25) expression under non- 
polarizing conditions, i.e., after 24 h stimulation with OVA peptide and APCs. Since the  
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Figure 10. Dietary FO does not affect surface CD25 expression on antigen-specific CD4+ T cells. Dietary 
n-3 PUFA suppressed IL-2 induced cell proliferation of Th1 cells. Purified CD4+ T cells from DO11.10 
Rag2-/- mice (different from Fig. 9) were cultured with OVA peptide in the presence of irradiated BALB/c 
splenocytes. After 24 h, cells were harvested, stained with 7-AAD and anti-CD25-PE, and analyzed by 
flow cytometry. PE beads were used to quantify CD25. (A) Unstimulated sample; (B) CD25 levels on 
CD4+ T cells from CO-fed mice; (C) CD25 levels on CD4+ T cells from FO-fed mice; (D) Overlay of the 
histogram of CD25 expression with PE beads. n=4 per diet group, and 5 mice were pooled per analysis.  
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culture period was relatively short, we omitted homologous mouse serum from the 
culture. CD25 was only measured on living cells as defined by non-staining of 7-AAD. 
Surprisingly, there was no difference (p >0.05) in the surface expression of CD25 
between FO and CO-fed mice (Fig.10). Cultures from CO and FO-fed mice exhibited a 
similar percentage of viable cells, CD25 positive cells with approximately same median 
fluorescence of intensity (Table 2). 
 
 
TABLE 2 
 
Dietary FO does not affect CD25 expression on antigen-stimulated CD4+ T cells 
 
Purified CD4+ T cells from CO or FO-fed DO11.10 Rag 2-/- mice were cultured with OVA 
peptide in the presence of irradiated splenocytes from chow-fed BALB/C mice. After 24 hour, 
the cells were harvested, stained with 7-AAD and anti-CD25-PE, and analyzed by flow 
cytometry. PE beads were used to quantify CD25 expression. 
                                                                   CO                          FO                           p 
% viable cells                                         31.9 (3.8)                    29.1 (4.0)                  0.35 
% CD25 positive cells                             66.7 (5.5)                   65.8 (4.8)                    0.81 
 
Median α-CD25-PE intensity                8811 (1382)                8488 (1410)                0.72     
 
 
DISCUSSION 
           A reduction in IFN-γ production by FO feeding has been reported by several 
investigators (75-77). Therefore, we hypothesized that FO suppresses Th1 development. 
Since genetic background determines default Th1/Th2 development of naïve Th cells 
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under neutral culture conditions, and the DO11.10 mice we used are on a Th1- prone 
B10.D2 background (30), it is not surprising that almost all cells were polarized to a Th1 
phenotype, i.e., >90% (Fig. 6). This is comparable to what has been achieved using 
similar Th1 polarizing conditions (90). Surprisingly, FO did not affect the frequency of 
Th1 cells generated under Th1 polarizing conditions, which strongly suggests that 
dietary FO does not affect the Th1 differentiation process. However, we did notice that 
the total number in culture by d 5 was significantly lower in FO-fed compared to CO-fed 
mice. In this type of culture, the BALB/c splenocytes actually die after d 2 (46,48), and 
the CD4+ T cells acquire the Th1 phenotype after 48 h (87). Since there was only rIL-2 
and rIL-12 in the culture media after d 2, and rIL-12 does not contribute to cell 
expansion (107), the modulation in cell number is likely due to the difference in the 
expansion of polarized Th1 cells. This is noteworthy, because an effective immune 
response depends not only on the acquisition of Th1 and Th2 phenotypes but also 
requires the survival and clonal expansion of differentiated effector cells. In addition, 
autoreactive Th1 cells are major players in some chronic inflammatory conditions. 
Therefore, inhibition of clonal expansion of Th1 cells could be a major mechanism to 
explain the beneficial anti-inflammatory effects of dietary FO. 
      In Th1 polarized cultures, two active processes exist: cell proliferation and apoptosis. 
With regard to apoptosis, we have previously shown that dietary FO promotes 
activation-induced cell death (AICD) of polarized Th1 cells (83). In antigen stimulated 
CD4+ T cells, a high level of apoptosis were observed in primary cultures and similarly 
in mouse T cell lines (47). Apoptotic cells were generated within each cell cycle. We 
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found that in IL-2 expanded Th1 cultures, and cells from FO and CO-fed mice displayed 
a similar percentage of apoptotic cells, indicating that IL-2 induced apoptosis did not 
play a role in diet-mediated differences in cell number (Fig. 8).  
       The finding of suppression of proliferation of polarized Th1 cells by dietary n-3 
PUFA is novel. Although suppressed T cell proliferation has been a widely reported 
effect of n-3 PUFA, this is the first study that clearly demonstrates the suppression of 
fully differentiated Th1 cells. Along these lines, previous reports about diminished IFN-γ 
production by n-3 PUFA could be due to a reduction in proliferation of Th1 cells rather 
than an impairment of Th1 differentiation (75,77). We demonstrated a reduction in the 
proliferation of antigen-specific CD4+ T cells and fully polarized Th1 cells, suggesting a 
main effect of dietary n-3 PUFA on the molecular machinery for proliferation as 
opposed to differentiation. In fact, there are similarities between the cultures of CD4+ T 
cells and polarized Th1 cells. Specifically, there are two distinct stages for the transition 
of CD4+ T cells to effectors (46). In cultures of antigen stimulated CD4+ T cells, 
efficient peptide presentation was limited to the first 1-2 d, with the late stage being IL-2 
driven antigen-independent expansion. Therefore, the proliferation of CD4+ T cells 
which we measured at day 3 was truly the proliferative response to IL-2.  
      Many studies have investigated the suppression of T cell proliferation by n-3 PUFA. 
Reduced IL-2 secretion by n-3 PUFA has been widely reported. The addition of EPA 
decreased IL-2 secretion by cultures of human peripheral blood mononuclear cells 
(PBMC) (108) and human Jurkat T cells (98). We have shown that dietary FO decreased 
IL-2 secretion in CD4+ T cells stimulated with anti-CD3/anti-CD28 (74). In a similar 
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antigen-specific model (74), Pompos et al. reported that dietary n-3 PUFA reduced OVA 
peptide stimulated IL-2 secretion from splenocytes from TCR transgenic mice (53). This 
could be true in our culture of CD4+ T cells. However, no study to date has determined 
whether exogenous rIL-2 is capable of rescuing suppression of proliferation by n-3 
PUFA. This is precisely what occurred in our Th1 polarized cultures, in the presence of 
the same amount of IL-2, dietary fish oil still suppressed proliferation of polarized Th1 
cells (Fig.9). This clearly suggests a new mechanism by which n-3 PUFA interfere with 
T cell clonal expansion, namely, by suppression of IL-2 R signaling.  
      IL-2 R signaling is regulated at both the transcriptional level and the post-
transcriptional level. AP-1 and NFAT regulate IL-2R transcription. EPA has been shown 
to suppress CD25 expression 24 h after stimulation of human PBMC stimulated with 
phytohemagglutinin (PHA) (108).  EPA also suppressed CD25 expression in human 
Jurkat cells compared with saturated fatty acids (98). In contrast to these findings, we 
did not find any difference in surface CD25 expression in CD4+ T cells isolated from 
CO-and FO-fed mice. This is the first time that the effect of n-3 PUFA on CD25 
expression in antigen-stimulated CD4+ T cell activation has been examined; all previous 
studies have used mitogenic stimuli (98,108). The reported CD25 decrease in previous 
studies could be due to reduced IL-2 secretion.  The similarity of expression of CD25 on 
the plasma membrane of CD4+ T cells from FO or CO-fed mice indicated the absence of 
regulation at the transcription level. It is possible, therefore, that n-3 PUFA exert an 
effect at the post-transcriptional level, possibly by modulating lipid rafts. Recently, the 
functional role of lipid rafts in the regulation of IL-2 R signaling has been revealed (67). 
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Similar to many receptors, IL-2R is not randomly distributed in the lipid bilayer of the 
plasma membrane. IL-2 receptor α, β, γ chains form preexisting complexes on the 
surface of T cells. IL-2 R α has been shown to cluster in lipid rafts on T cells, while the 
β and γ chains are in soluble fractions. IL-2 binding triggers dissociation of the α chain 
from lipid rafts and interaction with the β and γ chains, thus, initiating signal 
transduction (67). Disruption of lipid rafts in GM2/GD2 knockout mice resulted in 
inhibited T cell proliferation without changing the surface expression of IL-2 receptor 
(66). The suppression was found to be the result of a decrease in JAK1, JAK3 and 
STAT5 activation and delayed and reduced c-fos expression. We have previously shown 
that dietary n-3 PUFA suppress anti-CD3/anti-CD28 stimulated CD4+ T cell 
proliferation by modulating lipid rafts, inhibiting recruitment of PKC-θ to lipid rafts, and 
suppressing NF-κB and AP1 activation (82). This could also be true in antigen 
stimulated CD4+ T cells. It is possible that the n-3 PUFA incorporated into lipid rafts 
affect the interaction of IL-2 Rα chain with β and γ chains, thus, inhibiting IL-2 R 
signaling. It is also known that NF-κB is essential for post-differentiation IFN-γ 
production and clonal expansion in a Th1 response (109). Further investigation into the 
role of NF-κB activation in the suppression of antigen-stimulated CD4+ T cells by n-3 
PUFA is warranted. The possible involvement of changes in cell cycle by dietary n-3 
PUFA could also be investigated in culture systems using the vital dye CFSE (34).  
      In conclusion, we investigated how dietary n-3 PUFA affect OVA stimulated CD4+ 
T cell activation and differentiation into Th1 effector cells. We showed that dietary FO 
inhibits Th1 development by suppression of clonal expansion of polarized Th1 cells. We 
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also demonstrated that dietary n-3 PUFA inhibits proliferation of both antigen-
stimulated CD4+ T cells and IL-2 induced proliferation of antigen-specific Th1 cells. We 
propose that these changes could be due to modifications in lipid rafts by dietary n-3 
PUFA that could ultimately affect IL-2 receptor down-stream signaling. The exact 
mechanisms of involvement of lipid rafts in inducing these changes will be the subject of 
further investigation and will provide insight into why dietary n-3 PUFA have beneficial 
effects in Th1-mediated autoimmune diseases. 
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CHAPTER IV 
EFFECT OF DIETARY n-3 PUFA ON IN VIVO ANTIGEN SPECIFIC T CELL 
ACTIVATION AND Th1 DEVELOPMENT 
INTRODUCTION 
       Since we observed that dietary n-3 PUFA inhibited expansion of antigen-specific 
Th1 cells (chapter II), we designed an experiment to evaluate the outcome in vivo. Since 
CFA is an adjuvant which is known to promote Th1 differentiation (31), CFA plus OVA 
peptide was used to activate CD4+ T cells from DO11.10 Rag2-/- mice in vivo. We 
hypothesized that dietary FO would inhibit the expansion of CD4+ T cells from mice in 
response to immunization with OVA peptide in the presence of CFA.  
      Previously, studies with the original TCR transgenic mice on a BALB/c background 
showed that the intact TCR transgenic mice cannot be immunized directly to examine in 
vivo antigen-specific T cell activation because these mice mount an abnormal immune 
responses to antigen challenge in vivo due to the artificially high frequency of anti-
specific T cells (49). T cells from unimmunized TCR transgenic mice proliferate 
vigorously in response to OVA peptide in vitro, although die easily after direct 
immunization with OVA (Dr. Stephensen, U.C. Davis, personal communications). To 
avoid this complication, Kearney et al. developed an adoptive transfer system in which 
TCR transgenic T cells were injected into a non-transgenic recipient, and the transgenic 
T cells could be reliably detected using KJ1-26 mAb (49). This adoptive transfer 
protocol has been used to study the behavior of antigen-specific T cells following 
immunization for a wide range of experimental conditions (48,50,110). It has been 
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documented that the response following subcutaneous injection is characterized by 
marked accumulation of antigen-specific transgenic T cells only in the draining lymph 
nodes. We used this adoptive transfer approach to study the effects of dietary n-3 PUFA 
on antigen-driven T cell activation and differentiation into Th1 cells in vivo.  
      In addition to physically tracking the distribution and number of antigen-specific T 
cells, the in vivo proliferation of these cells was visualized by adoptive transfer of 
CFSE-labeled DO11.10 cells (52). Without immunization, the KJ1-26+ transgenic T 
cells remain as a single peak, whereas, KJ1-26 positive T cells undergo several cell 
divisions in the OVA-immunized host. 
      Using the adoptive transfer protocol, Anderson et al. (50) examined the effect of 
dietary lipids on in vivo proliferation of antigen-specific naïve CD4+ T cells. Using the 
original TCR transgenic mice on a BALB/c background, following 4 wk the feeding a 
FO diet (20% total fat) to recipient mice reduced the in vivo proliferation of CD4+ T 
cells compared with a soybean oil diet. The mechanisms of action are unknown. Here for 
the first time we demonstrate that dietary n-3 PUFA suppress in vivo antigen-specific 
Th1 development, but do not affect cell cycle progression. 
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MATERIALS AND METHODS 
Animals and diets 
       All experimental procedures using laboratory animals were approved by the 
University Laboratory Animal Care Committee of Texas A& M University. Pathogen-
free, female, young 4-6 wk of age BALB/c mice were purchased from the Frederick 
National Cancer Research Facility, Frederick, MD. DO11.10 Rag2-/- breeder mice were 
purchased from Taconic, bred and maintained at the LARR, Texas A & M University. 
Male B10.D2 mice were purchased from Taconic and were used as recipient mice in the 
adoptive transfer experiments. DO11.10 Rag2-/- mice (8-10 wk) were housed 5 per 
microisolator cage, and had free access to water and diet. They were fed a control semi-
purified diet containing 5% corn oil (CO) during the 7-d acclimation period, followed by 
2 wk feeding of either the same control diet or a fish oil (FO) diet (1% CO + 4% FO). 
Two groups of B10.D2 recipient mice were fed in parallel to donor DO11 mice. The 
diets met the NRC nutrition requirements and varied only in lipid content. The basic diet 
composition, expressed as g/100g was: casein, 20; sucrose, 42; cornstarch, 22; cellulose, 
6; AIN-76 mineral mix, 3.5; AIN-76 vitamin mix, 1; DL-methionine, 0.3; choline 
chloride, 0.2; Tenox 20A, 0.1; and oil, 5. The fatty acid composition of the diets, as 
determined by gas chromatography, is shown in Table 1. 
 
Chemical compounds and antibodies 
       Phorbol myristate acetate (PMA) was purchased from Sigma (St. Louis, MO). 
Ionomycin was purchased from Calbiochem-Novabiochem (San Diego, CA). KJ1-26-
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TC was purchased from Caltag Laboratories (Burlingame, CA). Hamster anti-mouse 
CD3e monoclonal antibody (clone145-2C11) was purchased from PharMingen (San 
Diego, CA). OVA323-339 peptide was synthesized by Biosource, International, Camrillo, 
CA using the following sequence: ISQAVHAAHAEINEAGR. CFA was purchased from 
Sigma (St. Louis, Missouri). Lympholyte-M was purchased from Cedarlane (Ontario, 
Canada).  
        
CD4+ T cell isolation, CFSE labeling and adoptive transfer  
       Spleens and lymph nodes (brachial and mesenteric lymph nodes) were taken from 
diet-fed DO11.10 Rag2-/- mice and placed in 3 mL RPMI complete media (RPMI 1640 
medium with 25 mM HEPES (Irvine Scientific, Santa Ana, CA) supplemented with 5% 
FBS, 1×105 U/L penicilin and 100 mg/L streptomycin (Irvine Scientific), 2 mM L-
glutamine, and 10 µM 2-mercaptoethanol). The spleens and lymph nodes were 
homogenized and filtered as described earlier (74). Total lymphocytes were enriched by 
density gradient centrifugation using Lympholyte-M. CD4+ T cells were purified from 
splenocytes by a negative selection column method described by Arrington et al. (74). 
Since preliminary data showed that greater than 90% of the lymph node cells from 
DO11.10 Rag2-/- mice were CD4+ T cells, the cells from lymph nodes were used directly 
after Lympholyte-M separation. CD4+ T cells from spleens were combined with 
lymphocytes from lymph nodes and labeled with CFSE as described (48). Briefly, cells 
were incubated with CFSE (10 µM) in PBS for 10 min at 37 oC. After washing three 
times with PBS, the labeled cells were adjusted to 3.0×107 cells/mL in sterile PBS and 
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100 µL were injected into each B10.D2 recipient mouse via the tail vein. Aliquots of 
labeled cells were cultured with PMA/Ionomycin to serve as the CFSE positive control 
for later flow cytometric analysis. 
 
Immunization 
       One day after adoptive transfer, selected recipient mice were immunized with OVA 
323-339 (300 µg) s.c. in CFA while others were not immunized (For details, see Appendix 
B-10).  
 
Flow cytometry 
       Three days after immunization, the brachial and inguinal lymph nodes were 
removed from individual mice, and processed into single cell suspensions. Living cells 
were counted, then stained with KJ1-26-PECy5 and analyzed by flow cytometry. 
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Figure 11. Dietary FO does not affect in vivo cell cycle progression of antigen-specific T cells. DO11.10 
Rag2-/- mice and B10.D2 mice were fed one week a CO diet followed by 2 wk of either the same CO diet 
or a FO diet. CD4+ T cells were isolated, labeled with CFSE and adoptively transferred to B10.D2 mice. 
B10.D2 mice were immunized 1 d after adoptive transfer with OVA peptide and CFA and maintained on 
the respective diets. Three days after immunization, draining lymph nodes were harvested, stained with 
KJ1-26 and analyzed by flow cytometry. A: unimmuned B10.D2 recipient mice fed the CO diet; B: 
immunized B10.D2 recipient mice fed the CO diet; C: unimmunized B10.D2 recipient mice fed the FO 
diet; D: immunized B10.D2 recipient mice fed the FO diet. 
 
 
 
 
RESULTS 
      In unimmunized B10.D2 mice, adoptively transferred CD4+ T cells (KJ1-26+) were 
identified as one cluster of cells, indicating a non-dividing resting state. Figure 11 
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showed the CFSE pattern of transgenic T cells from lymph nodes in these mice. The 
mice fed either the CO or FO diet had similar number of cells (Fig.11 A&C). In one of 
three immunized B10.D2 mice in each diet group, the KJ1-26+ T cells showed several 
cell divisions indicated by CFSE labeling. This would indicate a similar number of cell 
divisions in CO vs. FO-fed mice (Fig.11 B &D). Interestingly, the size of draining 
lymph nodes were smaller in immunized FO-fed B10.D2 mice compared with those fed 
the CO diet. Accordingly, total viable cells harvested from the lymph nodes were 
significantly lower in immunized FO-fed mice relative to CO-fed mice (Fig.12).  
 
DISCUSSION 
      To date, most studies examining the effects of n-3 PUFA on T cell function has 
utilized model systems employing transformed T cell lines or ex vivo methodology. We 
present evidence that dietary n-3 PUFA suppress T cell proliferation and the Th1 
response in vivo. Anderson et al. used a similar TCR transgenic model to study the effect 
of dietary n-3 PUFA on T cell activation in vivo, and reported no dietary effect on the 
frequency of CD4+ T cells (50). Similar to these data, we also observed similar numbers 
of transgenic T cells in unimmunized mice. Interestingly, Anderson et al. reported that 
the adoptively transferred CD4+ T cells in recipient mice fed an n-6 PUFA-enriched diet 
for 4 wk exhibited more proliferation cells in the recipient mice fed the FO diet.  
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Figure 12. Dietary FO suppresses in vivo antigen-specific T cell clonal expansion. DO11.10 Rag2-/- mice 
and B10.D2 mice were fed 1 wk a CO diet followed by 2 wk of either the same CO diet or a FO diet. 
CD4+ T cells were isolated, labeled with CFSE and adoptively transferred to B10.D2 mice. B10.D2 mice 
were immunized 1 d after adoptive transfer with OVA peptide and CFA and maintained on the respective 
diets. Three days after immunization, living cells counted. Values of different letters indicate 
significant difference (p=0.032). 
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      We also observed that CO and FO-fed mice displayed similar numbers of cell 
divisions as assessed by CFSE staining, but that there were more cells in each cycle in 
CO-fed compared with FO-fed mice. Overall, the total number of antigen-specific CD4+ 
T cells was lower in FO-fed mice. In addition, we showed that the dietary effect on the 
in vivo expansion of antigen-specific CD4+ T cells was not due to inhibition of cell cycle 
progression. This is in agreement with another study by Pompos et al. (53), in which he 
showed there was no difference in cell cycle progression in cultures of splenocytes from 
DO11.10 mice stimulated with OVA peptide. Thus, reduced number of antigen-specific 
CD4+ T cells in FO-fed mice must be explained by other mechanisms. 
      One alternative explanation could be enhanced apoptosis of Th1 cells by dietary FO. 
Switzer et al. showed that dietary FO enhanced AICD of purified CD4+ T cells and 
polarized Th1 cells in C57 BL/6 mice (83,84). However, we did not observe a diet effect 
on apoptosis in CD4+ T cells stimulated by antigen in vitro (see Fig. 8). Nonetheless, in 
vivo apoptosis in n-3 PUFA-fed mice is worthy of further investigation in this model. 
Another reason could be reduced IL-2 secretion. Pompos et al. (53) showed in cell 
culture that, CD4+ T cells from fish-oil fed mice proliferated less and secreted less IL-2 
compared with CO-fed mice in response to OVA.  
      With respect to future experiments, a couple of things could be examined. It is 
known that the DTH response is a typical Th1 response (104). So the DTH response 
could be examined in recipient mice following injecting OVA into the footpads (104). In 
addition, the recipient mice could be maintained on diet for more than 2 wk and the 
 81
 
serum levels of OVA-specific IgG2a and IgG1 could be measured to confirm a dietary 
effect on the Th1 response to OVA. 
      In summary, we established the adoptive transfer approach to study the effect of 
dietary n-3 PUFA on in vivo T cell activation and Th1 development. We have some 
interesting preliminary observations, however further work is needed to verify our initial 
findings and to investigate the mechanisms by which dietary n-3 PUFA appear to limit 
the accumulation of antigen-specific CD4+ Th1 cells in DO11.10 cell transfer recipients. 
Reciprocal adoptive transfers between DO11.10 and B10.D2 recipients fed each of the 
diets might clarify the effects of n-3 PUFA on the transferred T cells themselves, as 
opposed to a diet effect on the accessory factors and co-stimulatory environment 
provided by the recipient. 
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
       A large body of epidemiological and experimental studies shows that high dietary 
intake of n-3 PUFA ameliorates or decreases the risk for a variety of chronic 
inflammatory diseases (2,11,111). The two principal n-3 PUFA found in FO, EPA and 
DHA, are considered to be responsible for these beneficial effects.  Extensive studies 
have been carried out to understand the mechanisms by which dietary n-3 PUFA exert 
their anti-inflammatory effects. In the past 10 y, this laboratory and others have shown 
that the T cell is a primary target for n-3 PUFA-mediated immunomodulation 
(3,64,73,74,82-84,88).  Using murine models, we have demonstrated that feeding mice 
diets enriched in n-3 PUFA resulted in reduced T cell proliferation, reduced IL-2 
secretion, and diacylglycerol (73,74,81). There are at least two subsets of CD4+ T cells: 
Th1 and Th2 cells which are defined by their distinctive cytokine profiles. Th1 cells 
produce IFN-γ, IL-2 and lymphotoxin, Th2 cells produce IL-4, IL-5, and IL-10 (26). 
Evidence indicates that the Th1/Th2 balance is an important indicator for some 
autoimmune and inflammatory disease states (28,76,85). The effect of dietary n-3 PUFA 
on Th1 and Th2 development has not been studied. Previous findings in our lab indicate 
that CD4+ T cells from C57BL/6 mice stimulated with different agonists display distinct 
cytokine profiles, corresponding to Th1-like and Th2-like cells (74). The increased 
proliferation of Th2-like cells and the suppressed IL-2 secretion by Th1-like cells 
following FO feeding suggest that the anti-inflammatory effects of dietary n-3 PUFA 
could be due to the combination of suppressed Th1 function and enhanced Th2 
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activation (74). Therefore, we hypothesized that dietary n-3 PUFA alter Th1/Th2 
balance by enhancing Th2 development. 
      Our study on in vitro Th2 polarization of CD4+ T cells from C57BL/6 mice showed 
that dietary fish oil did not affect the percentage of Th2 cells generated under Th2 
polarizing conditions either with FBS or HMS (see Fig.3), indicating dietary n-3 PUFA 
has no direct effect on Th2 development. Interestingly, dietary fish oil significantly 
decreased the number of Th1 cells when cultured with HMS (see Fig.2). In addition, 
dietary n-3 PUFA significantly decreased Th1 cells and increased Th2 cells under 
neutral culture conditions (Fig.2). Thus, dietary n-3 PUFA shifted the Th1/Th2 balance 
towards the Th2 pole through suppression of Th1 cells (Fig.2). 
      To investigate how dietary n-3 PUFA affects Th1 development, we chose a model 
that allowed us to study the antigen-specific T cell response, DO11.10 Rag2 -/- mice. The 
DO11.10 transgenic mouse expresses a T cell receptor specific for the 323-339 aa 
peptide from ovalbumin (OVA 323-339) in an MHC class II-restricted fashion (54). This 
model is widely used as a model to study Th1/Th2 differentiation in vitro. Because it is 
Rag2 knockout, virtually all CD4+ T cells are TCR positive in this mouse strain (112). 
Preliminary studies were carried out to identify the optimal dose of OVA peptide and the 
proportion of antigen-presenting cells to stimulate CD4+ T cell proliferation in vitro.  
       We first tested the effect of dietary FO on proliferation of CD4+ T cells from 
DO11.10 Rag2-/- mice under neutral conditions. In agreement with our previous findings, 
we noted that dietary FO significantly suppressed antigen-specific proliferation of CD4+ 
T cells (Fig.5). However, the suppression was only seen when culture contained HMS 
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(Fig.5). This confirmed our earlier findings that the inclusion of HMS could maintain ex 
vivo lipid content of the membranes of cultured T cells and preserve the diet-induced 
changes during prolonged culture in vitro (83). 
      Following culturing CD4+ T cells from the DO11.10 mice under Th1 polarizing 
conditions, we found that almost all cells exhibited Th1 phenotype. FO and CO-fed mice 
displayed similar percentages of Th1 cells (Fig.6), indicating that n-3 PUFA do not 
affect Th1 differentiation. However, we noticed that the total number of T cells from 
FO-fed mice was significantly lower (Fig.7).  We showed that the difference in the 
number was not due to an enhancement in apoptosis (Fig.8), but due to reduced 
proliferation of polarized Th1 cells (Fig.9). The reduced proliferation did not appear to 
be due to altered surface expression of IL-2 Rα (CD25) (Fig.10 and Table 2). 
      Our novel observation that dietary FO suppressed clonal expansion of Th1 cells 
suggested that this could be an important mechanism for beneficial effects of FO in 
autoimmune and inflammatory diseases. We wished to confirm in vitro findings in 
whole animals. Therefore, we established an adoptive transfer system to examine 
antigen-specific in vivo T cell activation and Th1 development. In agreement with the in 
vitro findings, we observed significantly fewer antigen-specific CD4+ Th1 cells in FO-
fed recipient mice (Fig.12). This indicates that dietary FO inhibits Th1 development in 
vivo. However, the cell cycle analysis by CFSE staining showed that dietary FO did not 
inhibit cell cycle progression (Fig.11). This would suggest that the suppressed Th1 
clonal expansion by dietary FO must be due to other mechanisms such as effects on 
apoptosis in vivo or lymphocyte trafficking. 
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       In summary, we have demonstrated that dietary n-3 PUFA have different effects on 
Th1 and Th2 development, with selective inhibition of Th1 development, leading to a 
shift in the Th1/Th2 balance towards the Th2 pole. The suppression of antigen-specific 
Th1 development was not due to an inhibition of Th1 differentiation but due to  
suppression of clonal expansion. This is a novel finding because it indicates that dietary 
FO mainly affects the molecular machinery involved in cell proliferation, even though 
clonal expansion includes both cell proliferation and differentiation. Furthermore, we 
established the adoptive transfer system to study the effects of dietary n-3 PUFA on in 
vivo antigen-specific T cell activation and Th1 differentiation. This system could be 
utilized to examine the immunological properties of other dietary components.  
      Further studies are needed to elucidate the mechanisms by which dietary n-3 PUFA 
suppress proliferation of antigen-specific Th1 cells. These studies could focus on (1) 
how dietary n-3 PUFA affect lipid rafts and IL-2 receptor signaling; (2) how dietary n-3 
PUFA affect antigen-specific TCR signaling; (3) how dietary n-3 PUFA affect dendritic 
cell maturation; and (4) how dietary PUFA affect regulatory T cell function. These 
studies will contribute to our understanding of how Th1 responses can be modulated by 
dietary n-3 PUFA and elucidate possible targets of chronic inflammation in Th1-
mediated diseases. In addition, they will provide useful data for the establishment of 
dietary guidelines for dietary n-3 PUFA in terms of promoting optimal immune function. 
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A-1. Summary of Th2 polarization-method development 
 
1. PMA+anti-CD3 
Samples %IL-4+, IFN-γ- %IL-4-, IFN-γ+ %IL-4+, IFN-γ+ 
1 14.5 0.25 0.46 
2 12.4 0.061 0.22 
3 0.07 9.03 0.42 
4 0.02 9.25 0.64 
Mick-2 33.4 0.095 0.89 
Mick-2 39 0 1.52 
 
 
2. anti-CD3, PMA, IL-2, IL-4, anti-IFN-γ (48 h) 
 
Samples %IL-4+, IFN-γ- %IL-4-, IFN-γ+ %IL-4+, IFN-γ+ 
1 21.5 2.54 1.75 
2 17.6 2.78 1.4 
3 20.1 4.61 4.91 
 
 
3. PMA, Ionomycin, rIl-2, IL-4 (48 h) 
Samples %IL-4+, IFN-γ- %IL-4-, IFN-γ+ %IL-4+, IFN-γ+ 
1 12.9 4.03 1.84 
2 12.3 4.47 1.82 
 
 
4. anti-CD3, PMA, IL-2, IL-4, anti-IFN-γ (5 d) 
Samples %IL-4+, IFN-γ- %IL-4-, IFN-γ+ %IL-4+, IFN-γ+ 
1 7.22 17.2 2.33 
2 8.08 16.1 2.6 
 
 
5. anti-CD3, anti-CD28, rIl-2, IL-4, anti-IFN-γ (5 d) 
Samples %IL-4+, IFN-γ- %IL-4-, IFN-γ+ %IL-4+, IFN-γ+ 
1 6.65  0.046 
2 6.19  0.064 
3  6.11 0.081 
4  6.34 0.71 
 
6. PMA, Ionomycin, rIl-2, rIL-4 (5 d) 
Samples %IL-4+, IFN-γ- %IL-4-, IFN-γ+ %IL-4+, IFN-γ+ 
1 4.45 14.5 1.39 
2 3.95 14.4 1.31 
To be continued on next page 
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Objective: To determine the optimal culture conditions for Th2 polarization. 
 
Methodology: CD4+ T cells were isolated from chow-fed C57BL/6 mice and cultured as follows:  
(1) PMA (0.5 ng/ml) + anti-CD3 (10 µg/ml) for 48 h;  
(2) PMA (0.5 ng/ml) + anti-CD3 (10 µg/ml), with rIL-2 (20 ng/ml), IL-4 (10 ng/ml), anti-IFN-γ 
(10 µg/ml) for 48 h;  
(3) PMA (30 ng/ml) + Ionomycin (0.3 µM), with rIL-2 (20 ng/ml), rIL-4 (10 ng/ml) for 48 h;  
(4) PMA (0.5 ng/ml) + anti-CD3 (10 µg/ml), rIL-2 20 ng/ml), rIL-4 (10 ng/ml), anti-IFN-γ (10 
µg/ml) for 2 d, expanded with rIL-2 (20 ng/ml), rIL-4 (10 ng/ml) for anther 3 d;  
(5) anti-CD3 (1 µg/ml) + antiCD28 (5 µg/ml), rIL-2 (20 ng/ml), IL-4 (10 ng/ml), anti-IFN-γ (10 
µg/ml) for 2 d, expanded with rIL-2 (20 ng/ml), rIL-4 (10 ng/ml) for another 3 d;  
(6) PMA (30 ng/ml)+Ionomycin (0.3 µM), rIL-2 (20 ng/ml), rIL-4 (10 ng/ml) for 2 d, expanded 
with rIL-2 (20 ng/ml), rIL-4 (10 ng/ml) for another 3 d.  
 
Cells were harvested and restimulated with PMA and Ionomycin for analysis of intracellular 
cytokine staining for IL-4 and IFN-γ by flow cytometry as described in Appendix B-3.  
 
 
Conclusion: Among all tested conditions, No.2 seem to be optimal for Th2 polarization, so this 
condition was chosen for dietary studies on Th2 polarization.  
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A-2. Isotype controls for intracellular cytokine staining  
 
Samples               % IL-4 pos cells       %IFN-γ pos cells      %IL-4 neg, IFN-γ neg cells 
Nonstained              0.09                               0.18                                     99.3 
IgG-PE                    0.06                                0.16                                     99.3 
IgG-FITC               8.82e-3                            8.82e-3                                99.3 
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A-3. Genotyping the DO11.10 Rag 2-/- mice using whole blood 
 
 
 
 
 
 
 
 
 
 
 
 
 KJ1-26-TC
S
S
C
-H
ei
g
h
t
KJ1-26-TC
S
S
C
-H
ei
g
h
t
KJ1-26-TC
# 
C
el
ls
 
 
 
Objective: To confirm the presence of transgenic T cells in breeder DO11.10 Rag2-/- mice. 
 
Methodology: Whole blood was taken from the tail vein of four breeder mice and stained with 
KJ1-26-PECY5 and analyzed by flow cytometry. Results from four separate analysis showed 
that the transgenic T cells in the whole blood were 39.3%, 40.4%, 60.3%, 72.7%. 
 
Conclusion: The breeders have 39-73% transgenic T cells among lymphocytes in the blood. 
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A-4. Characterization of lymph node cells from DO11.10 Rag2-/- mice  
 
 
 
 
Objective: To determine the percentage of CD4+, TCR+ T cells in the lymph nodes of DO11.10 
Rag2-/- mice. 
 
Methodology: Brachial and mesenteric lymph nodes were isolated from chow-fed DO11.10  
Rag2-/- mice. Lymphocytes were enriched by Lympholyte-M then stained with anti-CD4-FITC 
and KJ1-26-CyPE5. 
 
Conclusion: Greater than 90% of lymphocytes in the lymph nodes of DO11.10 Rag2-/- mice were 
CD4+, TCR+, confirming the phenotype of the mice. These data support our decision to obtain 
purified CD4+ T cells, lymph nodes cells were used directly without using an additional column 
purification step. 
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A-5. Proliferation of whole splenocytes from DO 11.10 Rag2-/- mice 
 
 
 
 
 
 
 
Objective: To determine the optimal dose of OVA peptide to stimulate whole splenocytes from 
DO11.10 Rag2-/- mice. 
 
Methodology: Spleens were isolated from DO11.10 Rag2-/- mice and CD4+ T cells were isolated. 
Cells were cultured with different doses of OVA peptide for 72 h. Proliferation was measured by 
3H-Thymidine uptake as described. 
 
Conclusion: Whole splenocytes from DO11.10 Rag2-/- mice  proliferate in response to OVA in a 
dose dependent manner. The optimal dose of OVA peptide was 1 µM.  
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A-6. Proliferation of CD4+ T cells from DO11.10 Rag2-/- mice 
 
Objective: To determine the optimal condition for proliferation of purified CD4+ T cells from 
DO11.10 Rag2-/- mice. 
 
Methodology: CD4+ T cells were isolated from both spleens and lymph nodes as described as 
Appendix B-4 then cultured with irradiated BALB/c splenocytes for 3 d. Proliferation was 
measured by 3H-Thymidine uptake.  To be continued on next page. 
 
Conclusion: Proliferation of CD4+ T cells from DO11.10 Rag2-/- mice was dependent on both the 
number of CD4+ T cells and the number of APCs. Optimal conditions (4 and 5) were chosen for 
further experiments. 
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 A-7. Visualization of in vitro cell division of antigen-stimulated CD4+ T cells f
DO11.10 Rag2-/- mice 
bjective:  To detect cell proliferation of in vitro cultured cells by using CFSE. 
ethodology: CD4+ T cells were isolated from both lymph nodes and spleens of DO11.10
ag2-/- mice, labeled with CFSE, and cultured with OVA peptide and  irradiated BALB/c 
plenocytes for 3 d. Cells were harvested, stained with KJ1-26PECy5 and analyzed by flow
ytometry. A. CFSE staining of transgenic T cells; B. Histogram showing cell devisions; C
solated cells labeled with CFSE showed a single peak. 
onclusion: In vitro cell division can clearly be detected with CFSE labeling. 104
rom 
  
 
 Fresh 
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APPENDIX B 
PROTOCOLS 
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B-1. CD4+ T CELL ISOLATION 
 
1. Spleen Isolation 
 
Materials:  
Sterile tools (scissors, forceps, etc) 
70% Ethanol (EtOH) 
RPMI 1640 with 25 mM HEPES buffer, Irvine Scientific,  #9159 
Labeled 15 ml conical tube filled with 3 ml complete RPMI (RPMI 1640 with 5% FBS, 2 mmol/L L-
glutamine, 1 x 105 U/L penicillin, 100 mg/L streptomycin, and 10 µM 2-mercaptoethanol (2-ME)) 
 
Methods: 
1.  Sacrifice mice by CO2. 
2.  Place mice on their right side so the left side is facing up. 
3.  Apply 70% alcohol to the abdomen area. 
4.  Grab the skin of the abdomen with forceps and make a small incision. 
5.  Peel the skin to expose the membrane underneath. 
6.  Grab the membrane with forceps and cut the membrane to expose the organs. 
7.  Remove the spleen with forceps and trim the fat tissue with scissors. 
8.  Carefully remove as much fat as possible. 
9.  Place the spleens in a conical tube containing complete RPMI. 
 
2. Splenocyte preparation 
 
Materials: 
Sterile 7 ml glass-in-glass homogenizers, Kontes glass co.  
Sterile wire filters 
5 cc syringes 
20 gauge needles 
RPMI media 
15 ml conical tubes 
 
Methods: 
1. Transfer spleen and RPMI solution into a glass-in-glass homogenizer. 
2. Homogenize spleens until completely broken up (5-7 strokes). 
3. Assemble a 5 cc syringe, wire filter and 20 gauge needle unit and place on top of a newly labeled 15 ml  
conical tube. 
4. Remove the syringe plunger and transfer the appropriate spleen suspension into the assembled unit. 
5. Slowly reinsert the plunger to filter the suspension into the corresponding tube (be gentle with this 
step!). 
6. Fill each tube with RPMI for washing and centrifuge at 200g (rcf=200, rpm=1096, acc/bcc=6) for 5 min 
at RT. 
7. After the cells are done spinning, carefully aspirate the RPMI. Now the splenocytes are ready for next 
step of lymphocyte isolation. 
 
3. Isolation of lymphocytes by Lympholyte-M and cell preparation for the column elution steps 
 
Materials: 
Lympholyte-M (1x500 ml, Cedarlane, Ontario, Canada),  # CL5031 warm to RT 
R&D antibody cocktail (from R&D Mouse CD4 Subset Mini Column Kit, R&D Systems, Inc, Cat # 
MCD4C-1000) 
RPMI 1640 media with 25 mM HEPES buffer, Irvine Scientific, #9159 
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1X column wash buffer (diluted from 10X in the R&D Mouse CD4 Subset Mini Column Kit with 
sterile water (1500 ml, Baxter Healthcare Corporation, #2F7115)) 
 
Methods: 
1.    Add RPMI to the washed cells (add 2.0 ml for 30-40 × 106 cells or 3 ml for 60-80 × 106 cells    
according to Lan) and resuspend cells. 
2. Add an equal amount of Lympholyte-M by layering it beneath the suspended cells (insert the 
pipet tip into the bottom of the conical tube then dispense the Lympholyte-M slowly and 
carefully in order to see 2 distinct layers). 
3. Centrifuge the cells at 500g for 15 min (deactivate centrifuge break, for example, set acc/dcc=0 
for the Beckman CS-15centrifuge) at RT. 
Meanwhile, begin T-cell column preparation. 
When samples are done, 2 distinct layers (white on top and pink on bottom) and an interface band 
should be seen. 
4. Carefully remove the interface band with a 2 ml pipette and dispense it into a new 15 ml conical 
tube. 
5. Fill the conical tube with RPMI to wash and centrifuge at 300g for 5 min at RT (set acc/dcc back 
to 6).  
6. Aspirate off the RPMI and resuspend the cells in 1 ml 1X column wash buffer. 
7. Add 1 vial of monoclonal antibody cocktail (1ml) to suspend the cells and mix gently. 
8. Incubate cells at RT for 15 min. 
9. Wash cells in 10 ml 1X column wash buffer and spin at 300g for 5 min. 
10. Aspirate and repeat wash as step 9. 
11. Resuspend final cell pellet in 2 ml 1X column wash buffer. 
 
 
4. CD4+ T cell purification 
 
 
Materials: 
R&D Mouse T cell CD4 Subset column kit (Cat# MCD4C-1000)  
R&D column rack 
70% EtOH 
waste receptacle 
timers 
sterile 15 conical tubes 
1X column wash buffer (diluted from 10X in the R&D Mouse CD4 Subset Mini Column Kit with 
sterile water (1500 ml, Baxter Healthcare Corporation, #2F7115)) 
RPMI 1640 media with 25 mM HEPES buffer, Irvine Scientific, #9159  
 
Methods: 
1. Place the T-cell columns in the R&D column rack and place a waste receptacle beneath the 
columns. 
2. To prepare the columns, remove the top cap first and then remove the bottom cap. 
3. Allow the fluid within the column to drain until dripping stops; meanwhile rinse the outside of 
the column tip with 70% EtOH. 
4. Wash the column with 10 ml of 1X column buffer. 
5. Replace the waste receptacle with a newly labeled sterile15 ml conical tube. 
6. Apply 2 ml cell suspension to the top of the column. 
7. Allow the cells to sit in the column for 10 min at RT (start the timer when the dripping stops from 
the columns). 
8. Apply 10 ml of 1X column wash buffer to the column to elute the CD4+ T cells. 
9. Once the dripping from columns stopped again, centrifuge at 300 g for 5 min at RT. 
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10. Aspirate the supernatant and resuspend in 1 ml complete RPMI. Now cells are ready to be 
counted. 
 
 
5. Cell counting by hemacytometer 
 
Materials: 
Trypan blue (0.4%), Sigma, #T8154 
0.6 ml snap cap microcentrifuge tube, Nepture, # 3435.AS 
Hemacytometer 
Cell counter 
 
Methods: 
1. Add 198 µl of Trypan blue to a 0.6 ml epi-tube. 
2. Suspend the T cells and remove 2 µl and add to a sample tube with Trypan blue. 
3. Mix by pipetting up and down several times. 
4. Remove about 20 ul from this suspension and put in a hemacytometer. 
5. Count the viable white cells (count 200 cells at least). 
                      Total cells  
Cell number=  ----------------- × 104  × 102     cells/ml 
                                   squares 
Suspend the cells in complete RPMI at the concentration of 5 × 106 cells/ml.   
 
 
 
 
 
 
LITERATURE CITED: 
(74)  Arrington, J. L., Chapkin, R. S., Switzer, K. C., Morris, J. S. & McMurray, D. N. (2001) Dietary n-3 
polyunsaturated fatty acids modulate purified murine T-cell subset activation. Clin Exp Immunol 
125: 499-507. 
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B-2. Th2 Polarization 
 
Materials: 
Sterile 24-well plates, Corning Incorporated, #3524 
Th2 polarizing agents final concentrations diluted in complete RPMI except anti-CD3:  
• 10 µg/ml αIFNγ (R46A2) Pharmingen Cat#554430 
• 10 ng/ml rIL-4                   Pharmingen Cat#550067 
• 20 ng/ml rIL-2                   R&D Systems, Inc, Cat#402-ML 
• 1 µg/ml anti-CD3               Pharmingen Cat#55305, diluted in sterile PBS            
• 0.5 ng/ml PMA                  Sigma, St Louis, MO     Cat#P-8139 
• 500 nM Ionomycin           Calbiochem-Novabiochem, San Diego, CA  
                                                Cat# 407952 
• 5% complete RPMI 1640 media (with 5% FBS, or 5% homologous mouse serum (HMS) 
(2.5% FBS+2.5% HMS)) 
 
 
Methods: 
1. The day before the experiment, prepare anti-CD3 solution in sterile PBS. Coat the 24-well plate 
with 300 µl of 1 µg/ml anti-CD3 per well, incubate at  4 oC overnight. 
2. Prepare the Th2 cocktail at double concentration of the final one in complete RPMI with 5% FBS 
or HMS, i.e., PMA, 1 ng/ml; rIL-4, 20 ng/ml; rIL-2, 40 ng/ml;α-IFNγ, 20 ug/ml. 
3. Add 1 ml Th2 cocktail in each well of the 24-well plate. 
4. Add 1 ml cell suspension ( 5 x 106 cells/ml) in each well. 
5. Incubate at 37oC for 2 days (day0 and day1). The cytokines are analyzed as described in 
Appendix B-3. 
 
LTIERATURE CITED: 
(83) Switzer, K. C., Fan, Y. Y., Wang, N., McMurray, D. N. & Chapkin, R. S. (2004) Dietary n-3 
polyunsaturated fatty acids promote activation-induced cell death in Th1-polarized murine CD4+ 
T-cells. J Lipid Res 45: 1482-1492. 
 
(90)  Kato, Y., Negishi, T., Furusako, S., Mizuguchi, K. & Mochizuki, H. (2003) An orally active Th1/Th2 
balance modulator, M50367, suppresses Th2 differentiation of naive Th cell in vitro. Cell 
Immunol 224: 29-37. 
 
(93)  Wurster, A. L., Rodgers, V. L., Satoskar, A. R., Whitters, M. J., Young, D. A., Collins, M. & 
Grusby, M. J. (2002) Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the 
differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med 196: 969-
977. 
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B-3. Intracellular Cytokine Staining 
 
       Materials: 
       50 ml conical tube 
       12×75 Polystyrene tubes for flow cytometry, Falcon, #352054 
       Aluminum foil 
       Lympholyte-M (1x500 ml, Cedarlane, ontario, Canada),  # CL5031 warm to RT 
      0.2 uM HT TuffrynR membrane filter, PALL life scientific, #4192 
       Complete RPMI 1640 with 5% FBS 
       PMA final concentration 10 ng/ml                Sigma, St Louis, MO     Cat#P-8139 
       Ionomycin final concentration 500 nM      Calbiochem-Novabiochem, San Diego, CA  
                                                                                                             Cat# 407952 
       BD Cytofix/Cytoperm solution    from BD Cytofix/Cytoperm Kit            Cat#554715 
       BD Perm/Wash solution from BD Cytofix/Cytoperm Kit, Cat#554715, 10X (dilute 1:10 in distilled   
water prior to use)  
       Golgistop from BD Cytofix/Cytoperm Kit, Cat#554715 (8 µg in 6 ml complete media) to inhibit 
intracellular protein transport processes                                       
       (Golgistop should be in cell culture no more than 12 h due to toxicity) 
       Staining antibodies and controls 
• αIL-4-PE         Pharmingen Cat#554435 
• αIFNγ-FITC    Pharmingen Cat#554411 
• IgG-PE             Pharmingen Cat#554685 
• IgG-FITC         Pharmingen Cat#554684 
       Fc Block, Pharmingen Cat#553142, (stock 0.5 mg/ml, final concentration 5 µg/ml in staining buffer) 
         
       Staining buffer 
• Dulbecco’s PBS without Mg2+ or Ca2+ , Invitrogen Corporation 14190-144 
• 1% heat-inactivated fetal bovine serum (FBS) 
• 0.09% (w/v) sodium azide, Sigma, #S-2002 
• Adjust pH to 7.4-7.6, filter through 0.2 µm pore membrane and store at 4 oC 
 
       Methods: 
1. Cell stimulation at day2 following Th2 polarization as described in Appendix B-2. 
1.1 Media preparation: prepare complete RPMI with PMA (2ng/ml), Ionomycin (1 µM), and 
Golgistop (8 µl in 6 ml complete media). 
1.2 Harvest cells by pipeting up and down for a few times, then deliver cells into a conical tube. 
1.3 Fill the tube with RPMI for washing and centrifuge at 200 g for 5 min at RT. 
1.4 Resuspend in 2 ml RPMI. 
1.5 Add equal amount of Lympholyte-M by layering it beneath the suspended cells (insert the 
pipet tip into the bottom of the conical tube then dispense the Lympholyte-M slowly and 
carefully in order to see 2 distinc layers). 
1.6 Centrifuge at 500g for 15 min with break off. 
1.7 Remove the interface into a new 15 ml conical tube, fill with RPMI, centrifuge at 300g for 5 
min with break on. 
1.8 Aspirate and resuspend cells in complete media. 
1.9 Cell counting. 
1.10 Resuspend cells at 2 × 106 cells/ml in complete media. 
1.11 Add 0.5 ml complete RPMI with PMA, Ionomycin and Golgistop to each well; add 0.5 ml 
cells to each well. 
1.12 For nonstimulated cells, add 0.5 ml complete RPMI into each well and add 0.5 ml cells. 
1.13 Incubate the cells for 5h at 37 oC incubator. 
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1.14 Meanwhile prepare anti-cytokines dilutions in staining buffer. These antibody conjugates 
are light sensitive, always dim light when prepare these solutions. 
                       αIL-4-PE: prepare 2.7 µg/ml, 0.9µg/ml, 0.3µg/ml 
                       αIFNγ-FITC: 4.8µg/ml, 2.4µg/ml, 0.6µg/ml 
                       IgG-PE: same as αIL-4-PE 
                       IgG-FITC: same as αIFNγ-FITC 
Keep the prepared solutions on ice and cover with aluminum foil. 
             
2. Harvest cells 
Harvest cells from each well into corresponding 1.5 ml microcentrifuge  tubes and spin down the 
medium containing Golgistop by centrifuging at 200 g for 5 min at 4 oC. 
3. Block Fc receptors 
Add 100 µl Fc Block to each tube, resuspend the cells, incubate for 15 min at 4 oC, then wash 
cells with staining buffer by adding 1 ml staining buffer and centrifuge at 200g for 5 min at 4 oC. 
4. Fix and permeabilize cells 
Resuspend the cells in 250 µl BD Cytofix/Cytoperm solution, incubate for 20 min at 4 oC, then 
wash cells 2 times in 1 ml 1X BD Perm/Wash solution by centrifuging at 200 g for 5 min at 4 oC. 
5. Staining for intracellular cytokines 
Thoroughly resuspend fixed/permeabilized cells in 100 µl anti-cytokine antibody or appropriate 
negative control 
Negative controls: Unstained, IgG-PE, IgG-FITC. 
Incubate cells at 4 oC for 30 min in the dark. Wash cells 2 times in 1 ml 1X BD Perm/Wash 
solution by centrifuging at 200 g for 5 min at 4 oC and resuspend in 500 µl Staining buffer 
6. Flow cytometry 
Right before flow cytometric analysis, transfer the cells into 12×75 Polystyrene tubes for flow 
cytometry at room temperature, wrap in aluminum foil and bring to Dr.Smith’s lab (contact 
information: rosmith@cvm.tamu.edu). 
                 
                Samples to be analyzed: unstained, stained with αIL-4-PE only, stained with αIFN-γ-FITC only,  
                stained with αIL-4-PE and αIFN-γ-FITC.  End point: intracellular cytokine profiles. 
          
 
 
 
LITERATURE CITED: 
(83) Switzer, K. C., Fan, Y. Y., Wang, N., McMurray, D. N. & Chapkin, R. S. (2004) Dietary n-3 
polyunsaturated fatty acids promote activation-induced cell death in Th1-polarized murine CD4+ 
T-cells. J Lipid Res 45: 1482-1492. 
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B-4. Proliferation Assay of CD4+ T cells from DO11.10 mice 
 
1. Antigen presenting cells (APC) preparation 
 
1.1. Spleen Isolation 
 
Materials:  
Sterile tools (scissors, forceps, etc) 
EtOH 
RPMI 1640 with 25 mM HEPES buffer, Irvine Scientific,  #9159 
Labeled 15 ml conical tube filled with 3 ml complete RPMI (RPMI 1640 with 5% FBS, 2 mmol/L L-
glutamine, 1 x 105 U/L penicillin, 100 mg/L streptomycin, and 10 µM 2-mercaptoethanol (2-ME)) 
 
 
Methods: 
1. Sacrifice one BALB/C mouse by CO2. 
2. Place mouse on the right side so the left side is facing up. 
3. Apply 70% alcohol to the abdomen area. 
4. Grab the skin of the abdomen with forceps and make a small incision. 
5. Peel the skin to expose the membrane underneath. 
6. Grab the membrane with forceps and cut the membrane to expose the organs. 
7. Remove the spleen with forceps and trim the fat tissue with scissors. 
8. Carefully remove as much fat as possible. 
9. Place the spleen in a conical tube containing complete RPMI. 
 
1.2. BALB/c spleen cells preparation 
 
Materials: 
Sterile glass-in-glass homogenizers 
Sterile wire filters 
5 cc syringes 
20 gauge needles 
complete RPMI (RPMI 1640 with 5% FBS, 2 mmol/L L-glutamine, 1 x 105 U/L penicillin, 100 mg/L 
streptomycin, and 10 µM 2-mercaptoethanol (2-ME)) 
15 ml conical tubes 
Ovalbumin (OVA) peptide, synthesized by Biosource, Inc. 
 
Methods: 
1.    Transfer spleen and RPMI solution into a glass-in-glass homogenizer 
2. Homogenize spleen until completely broken up (5-7 strokes) 
3. Assemble a 5 cc syringe, wire filter and 20 gauge needle unit and place on top of a newly labeled 15 
ml conical tube 
4. Remove the syringe plunger and transfer the appropriate spleen suspension into the assembled unit 
5. Slowly reinsert the plunger to filter the suspension into the corresponding tube (be gentle with this 
step!) 
6. Fill the tube with RPMI for washing and centrifuge at 200g (rcf=200, rpm=1096, acc/bcc=6) for 5 
min at RT 
7. After the cells are done spinning, carefully aspirate the RPMI. Fill the tube with complete RPMI to 
top and put on ice. ( Air will reduce irradiation in next step so there should be no air in the tube) 
8. Take the tube to Dr.Walker (979-412-3128) or Vickie Weir (979-412-3130) at large animal clinic for 
irradiation. 
9. Irradiate the tube at 2600 rads. 
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10. Centrifuge the tube at 300g for 5min. Aspirate off the RPMI. Resuspend in 1 ml complete RPMI and 
count the cells. Centrifuge again and resuspend the cells with complete media with OVA (0.1 uM-
1uM) at desired concentration (for example, 5x106 cells/ml). 
 
 
2.DO11.10 CD4+ T cells preparation 
 
2.1. Spleen and lymph nodes Isolation 
 
Materials:  
Sterile tools (scissors, forceps, etc) 
EtOH 
Labeled 15 ml conical tube filled with 3 ml complete RPMI (RPMI 1640 with 5% FBS, 2 mmol/L L-
glutamine, 1 x 105 U/L penicillin, 100 mg/L streptomycin, and 10 µM 2-mercaptoethanol (2-ME)) 
 
Methods: 
1. Sacrifice mouse by CO2 
2. Place a mouse with abdomen facing up 
3. Apply 70% alcohol to the abdomen area 
4. Grab the skin of the abdomen with forceps and make a small incision 
5. Peel the skin to expose the membrane underneath 
6. Find the lymph nodes under the arms and hind legs. Pinch the lymph nodes off and  tease off the 
connecting fat, put them in a tube containing complete RPMI.  
7. Make an incision in the membrane at abdomen and find the mesenteric node. Get it and put in the above 
tube. 
6. Turn the mouse around and find the spleen. 
7. Remove the spleen with forceps while cutting the fat tissue with scissors 
8. Carefully remove as much fat as possible 
9. Place the spleen in a conical tube containing complete RPMI 
 
 
2.2. Spleen and lymph node cell preparation 
 
Materials: 
Sterile glass-in-glass homogenizers 
Sterile wire filters 
5 cc syringes 
20 gauge needles 
RPMI media 
15 ml conical tubes 
 
Methods: 
       1.    Transfer spleen and lymph nodes into corresponding glass-in-glass homogenizers 
2. Homogenize spleens until completely broken up (5-7 strokes) and homogenize the lymph nodes 
the same way (only 3-4 strokes will be enough). 
3. Assemble a 5 cc syringe, wire filter and 20 gauge needle unit and place on top of a newly labeled 
15 ml conical tube 
4. Remove the syringe plungers and transfer the appropriate spleen and lymph node suspension into 
the assembled units 
5. Slowly reinsert the plunger to filter the suspension into the corresponding tube (be gentle with 
this step!) 
6. Fill each tube with RPMI for washing and centrifuge at 200g (rcf=200, rpm=1096, acc/bcc=6) for 
5 min at RT 
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7. After the cells are done spinning, carefully aspirate the RPMI. 
 
2.3. Isolation of lymphocytes by Lympholyte-M  
 
Materials: 
Lympholyte-M (1x500 ml, Cedarlane, Ontario, Canada),  # CL5031 warm to RT 
RPMI media 
  
Methods: 
1.    Add RPMI to the washed cells (add 3ml for cells combined from 5 spleens or lymph nodes from 
5  DO11.10 mice, cells from spleens and lymph nodes from 5 mice are just above the required 
minimum number of cells for optimum output for the column) and resuspend cells. 
2. Add an equal amount of Lympholyte-M by layering it beneath the suspended cells (insert the 
pipet tip into the bottom of the conical tube then dispense the Lympholyte-M slowly and 
carefully in order to see 2 distinct layers) 
3. Centrifuge the cells at 500g for 15 min (deactivate centrifuge break by setting acc/dcc=0) at RT 
              When samples are done, 2 distinct layers (white on top and pink on bottom) and an                
              Interface band should be seen. 
4. Carefully remove the interface band with a pipette and dispense it into a new conical tube 
5. Fill the conical tube with RPMI, suspend the cells and centrifuge at 300g for 5 min at RT 
6. Aspirate off the RPMI and wash again 
7. Resuspend cells in 1 ml complete RPMI.  Combine the cells prepared from spleens and lymph 
nodes. . 
 
2.4 CD4+ T cell purification 
 
 
Materials: 
R&D CD4+ columns  (Cat# MCD43) at RT 
R&D column rack 
70% EtOH 
waste receptacle 
timers 
sterile 15 ml conical tubes 
1X column wash buffer (diluted from 10X with sterile water) 
complete RPMI 1640 media 
 
Methods: 
1.   Place the T-cell columns in the R&D column rack and place a waste receptacle beneath the  
columns. 
2. To prepare the columns, remove the top cap first  and then remove the bottom cap. 
3. Allow the fluid within the column to drain until dripping stops; meanwhile rinse the outside of 
the column tip with 70% EtOH. 
4.  Wash the column with 6 ml of 1X column buffer. 
5. Replace the waste receptacle with a newly labeled sterile15 ml conical tube. 
6. Apply 2 ml cell suspension to the top of the column. 
7. After the dripping stopped, allow the cells to sit in the column for 10 min at RT. 
8. When the dripping stopped again, apply 8 ml of 1X column wash buffer to the column to elute 
the CD4+ T-cells. 
9. Once all the T cells have been collected, centrifuge at 300 g for 5 min at RT. 
10. Aspirate the supernatant and resuspend in 1 ml complete RPMI. Now cells are ready to be 
counted. 
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2.5. Cell counting by hemacytometer 
 
Materials: 
Trypan blue 
Small sample tubes 
Hemacytometer 
Cell counter 
 
Methods: 
6. Add 198 µl of Trypan blue to the empty sample tubes 
7. Suspend the T cells and remove 2µl and add to a sample tube with Trypan blue 
8. Mix by pipetting up and down several times 
9. Remove about 20 µl from this suspension and put in a hemacytometer 
10. Count the viable white cells (count at 200 cells at least) 
                      Total cells  
Cell number=  ----------------- × 104  × 102     cells/ml 
                                   squares 
Suspend the cells in complete RPMI at the concentration of  106 cells/ml.   
 
3. 3H-Thymidine uptake 
 
Materials: 
Sterile 96 well round bottom plates 
Complete RPMI 
Lyophilized OVA peptide, synthesized by Biosource 
OVA peptide solution final concentration:  0.1µM, 1µM 
Acetic acid, HPLC grade, Fisher Scientific, #A35-500 
1.5 ml ultra low retention microcentrifuge microtubes, PHENIX research products, #MH-815 SA  
50 ml sterile filtration system with 0.22 um Millipore Express Plus membrane, Millipore, 
#SCGP00525 
Falcon polypropylene tubes 
Multi-petter 
Sterile solution basins 
 
Preparation of OVA peptide stock solution (1 mg/ml in 0.05% acetic acid) 
1. Dissolve 1 mg lyophilized peptide in 0.5 ml sterile water 
2.Preare 0.5% acetic acid solution: 500 µl high purity acetic acid is added to 100 ml 
   sterile water, then filtered through a 50 ml sterile filter 
3. To a low retention microcentrifuge tube, add 360 µl sterile water and 90 µl 0.5% acetic acid 
4.Take 450 µl of the above peptide in step 1 to this low retention epp (this is the stock), the rest for 
peptide concentration analysis by Dr. Larry dangott’s lab on campus (the report says the peptide 
concentration is 32.30 µg/15 µl = 608.6 µM for stock) 
5. aliquote to 20 µl and store <-70oC 
 
 
Methods: 
Day 0 
1. Prepare OVA peptide solution in complete RPMI containing the irradiated BALB/c spleen cells. 
2. Label the wells of a sterile 96 well plate for RPMI and respective concentrations of OVA peptide 
( 3 for each) 
3. Add 100 µl of OVA peptide and BALB/c splenocyte suspension  in complete RPMI to the 
designated wells 
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4. Add 100 µl of CD4+ T cells. 
5. Thoroughly mix the cells by pipetting up and down. 
6. Tape the lid and place in 37 oC incubator for 72 h 
 
      Day3 
1. Remove the plate from the incubator and check under microscope to ensure cells have 
proliferated (notice the expansion of cell mass) 
2. Pipette 1600µl complete RPMI into a 15 ml conical tube 
3. Make a plate map by numbering each well of the plate 
4. Bring the plate and RPMI over to Dr.McMurray’s lab 
5. In the room containing the cell harvester, find the conical tube of 100 µCi 3H-Thymidine solution 
in the refrigerator. 
6. Dilute the 3H-Thymidine 1:5 to 20 µCi 
Add 400 µl of 100 µCi 3H-Thymidine solution +1600 µl complete RPMI 
7. Add 50 µl of 20 µCi 3H-Thymidine to each well 
8. Incubate the cells in 37 oC incubator for 5-6 h 
9. After incubation, prepare a filter paper 
10.  Turn on vaccum pump 
11. Run H2O through the harvester by pushing  COLD button and ensure that all probes are 
aspirating and dispensing well and wash the system using HOT vaccum. 
12. Place a filter paper on the top compartment of the cell harvester and place sample plate 
underneath the probes 
13. Suck up contents using HOT vaccum and wash with water at least 7 times 
14. Remove top compartment with vaccum on to help dry the filter 
15. Once filter looks dry, remove the template with filter on it 
16. Label scintillation vials with designated numbers of each filter disc 
17. Using forceps, gently push out the perforated discs of filter paper and place them in appropriate 
scintillation vial 
18. Then fill each scintillation vial with 10 ml scintillation fluid 
19. Bring scintillation vials over to beta/gammer counter at Kleberg Biochemistry Lab 
20. Load scintillation vials in rack from left to right and place a red STOP rack behind the last rack 
21. Use Counter User1 and AutoCount (about1 min for each vial) 
 
 
 
LITERATURE CITED: 
(30)  Hsieh, C. S., Macatonia, S. E., O'Garra, A. & Murphy, K. M. (1995) T cell genetic background 
determines default T helper phenotype development in vitro. J Exp Med 181: 713-721. 
(74)  Arrington, J. L., Chapkin, R. S., Switzer, K. C., Morris, J. S. & McMurray, D. N. (2001) Dietary n-3 
polyunsaturated fatty acids modulate purified murine T-cell subset activation. Clin Exp Immunol 
125: 499-507. 
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B-5. Protocol for Genotyping of DO11.10 Rag2-/- Mice 
 
Materials: 
Fc Block (stock 0.5 mg/ml) Pharmingen #553142 
KJ1-26-TC specific for the transgenic T cell receptor ( stock 0.1 mg/0.5 ml) Caltag Laboratories, 
Burlingame, CA, MM7504 
Mouse Erythrocyte Lysing Kit  R&D systems Cat#WL-2000 
10 X concentration lysis buffer from Mouse Erythocyte Lysing Kit, R&D systems, #WL-2000 
10 X concentration fixative from Mouse Erythocyte Lysing Kit, R&D system, #WL-2000 
10 X washing buffer from Mouse Erythrocyte Lysing Kit  R&D systems, #WL-2000 
12x75 mm 5 ml polystyrene round-bottom tube, Falcon, #352054 
2.0 ml microtubes, Fisher Scientific, #02-681-266  
PBS, Invitrogen Corporation, #14190-250 
BSA, IgG free, Boehringer Mannheim, #100018 
Microhematocrit capillary tubes, non heparinized blue coded tip, Fisher Scientific, #02-668-68 
Heparin, 5000 units/ml, Elkins-simn, Inc, #NDC0641-2460-41 
MinisealR  microplate, DADE, #B4424-1 
 
Protocol: 
 
1. Nick the tail of a DO11.10 mouse to collect a few drops of blood into a 2.0 ml microtubes, Fisher 
Scientific, #02-681-266 as described in Appendix B-6.  
2. Add about 20 µl  heparin in microhematocrit capillary tubes, then fill with blood, seal with the 
MinisealR microplate without inversion mixing, put on ice, bring back to lab. 
3. Break the tube and release the blood to a new 2.0 ml microtubes, Fisher Scientific, #02-681-266, take 
50 ul into a 12x75 mm 5 ml polystyrene round-bottom tube. 
4. Add Pharmingen Fc block (1 µl  stock/50 µl blood), vortex, incubate at room temperature for 10 mins. 
5. In the dark, add 10 µl KJ1-26 monoclonal antibody MM7504 (200 µg/ml stock diluted to 5 µg/ml 
with 1 X  washing buffer) and incubate in the dark for 30 mins on ice. 
6. Lyse the cells by incubation with 100 µl 1X M-lysis (diluted from 10X M-lyse buffer from Mouse 
Erythrocyte Lysing Kit  R&D systems Cat#WL-2000) buffer for 10 mins at room temperature. 
7. Wash one time with 1 ml PBS, 200g, 5 min, 4 oC. 
8. Repeat lysis two times until the pellet is no more red. 
9. Resuspend in 300 µl PBS containing 1% BSA at room temperature, bring to Dr. Smith’s lab.  
10. If the flow cytometry detection is delayed for 1 hour, fix the cells with the 10X fixative from the 
Mouse Erythrocyte Lysing Kit R&D systems Cat#WL-2000 (add 100 µl 10X fixative to 1 ml cells). 
 
End point: to detect percentage of TCR positive cells in the whole blood. Unstained samples and 
stained samples with KJ1-26-TC. 
 
Follow instructions from the Mouse Erythrocyte Lysing Kit  R&D systems Cat#WL-2000. 
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B-6. Collect Blood from Mice – Tail Nick 
 
Materials: 
red light , 250 w, Underwriters Laboratories portable lamp, BD-19, 935 
restrainer, hand made from an empty pipit tip box with a hole on the edge  
70% alcohol 
scalpel 
2-ml microcentrifuge  tube, Fisher Scientific, #02-681-266 
gauze 
 
 
Protocol: 
1. Put a mouse into a plastic container, heat it with red light until it jumps. 
2. Put the mouse into a restrainer 
3. Clean the tail with 70% alcohol 
4. Using a scalpel blade make a small nick on the underside of the tail 
5. Hold the tail so that the tip points to the floor 
6. Allow blood to drip into a collection tube 
7. When finished apply slightly pressure with a piece of gauze about 15 sec to insure homeostasis 
 
 
Follow instructions from LARR. 
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B-7. Protocol for DO11.10 Th1 Polarization 
 
1. CD4+ T cells isolation.  Same as described in Appendix B-4. BALB/c splenocytes were prepared as 
described in Appendix B-4. 
 
2. Cell counting by hemacytometer 
 
Materials: 
Trypan blue (0.4%), Sigma, #T8154 
0.6 ml snap cap microcentrifuge tubes, Neptune, #3435.AS 
Hemacytometer 
Cell counter 
 
Methods: 
1.    Add 195 µl of Trypan blue to the empty sample tubes. 
2.    Suspend the T cells and remove 5 µl and add to a sample tube with Trypan blue. 
3. Mix by pipetting up and down several times. 
4. Remove about 20 ul from this suspension and put in a hemacytometer. 
5. Count the viable white cells (count at 200 cells at least) 
                      Total cells  
Cell number=  ----------------- × 4×105     cells/ml 
                                   squares 
Suspend the cells in complete RPMI at the concentration of 5 × 105 cells/ml.   
 
 
 
Th1 polarization 
 
Materials: 
Sterile 24-well plates 
Th1 polarizing agents final concentration diluted in complete media:  
• 10 µg/ml αIL-4 (11B.11)      gift from NCI 
• 5 ng/ml rIL-12                      PharMingen #554592 
• 20 ng/ml rIL-2                      R&D Systems #402-ML 
• T cell media (complete RPMI1640 with 5% FBS or 5% HMS) 
 
 
Methods: 
1.Prepare the Th1 cocktail at double concentration of the final one in complete RPMI (with 5% FBS).  
2.Resuspend the irradiated BALB/c cells in Th1 cocktail at the concentration of 2.5 x 105 cells/ml. 
3.Add 1 ml BABL/c (2.5 x 105 cells) in Th1 cocktail in each well of the 24-well plate. 
4.Add 1 ml DO11.10 CD4+ T cells (5.0 x 106 cell/ml) suspension in each well. 
5.Incubate at 37oC for 2 days. 
6.At day2 and day3, harvest cells and wash once with RPMI. 
7.Resuspend cells in fresh 10% FBS containing only rIL-2 and rIL-12. 
8. Incubate at 37 oC until day 5. 
 
 
Intracellular cytokine staining 
 
Materials: 
       50 ml conical tube 
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       12×75 Polystyrene tubes for flow cytometry 
       Aluminum foil 
       Lympholyte-M 
       Complete RPMI with 5% FBS 
       PMA 10 ng/ml                Sigma, St Louis, MO     Cat#P-8139 
       Ionomycin  1 µg (1.33 µM)      Calbiochem-Novabiochem, San Diego, CA  
                                                Cat# 407952 
       BD Cytofix/Cytoperm solution    from BD Cytofix/Cytoperm Kit            Cat#554715 
       BD Perm/Wash solution, 10X (dilute 1:10 in distilled water prior to use) Cat#554715 
       Golgistop (final concentration: 4 µg in 6 ml media) to inhibit intracellular transport  
        processes        #554715                                        
       (Golgistop should be in cell culture no more than 12 h due to toxicity) 
       Staining antibodies and controls 
• αIL-4-PE                 Pharmingen Cat#554435 
• αIFNγ-FITC            Pharmingen Cat#554411 
• IgG-PE                     Pharmingen Cat#554685 
• IgG-FITC                 Pharmingen Cat#554684 
• Mick-2 cells (Mouse intracellular cytokine positive control cells)  Pharmingen  Cat #554653 
       Fc Block (dilute stock to final concentration 5 µg/ml in staining buffer)     Pharmingen Cat#553142 
       KJ1-26-PE-TC monoclonal antibody to transgenic TcR, Caltag Laboratories #MM7506 (diluted to 2 
ug/ml in staining buffer before use) 
       Staining buffer 
• Dulbecco’s PBS without Mg2+ or Ca2+ 
• 1% heat-inactivated FBS 
• 0.09% (w/v) sodium azide 
• Adjust pH to 7.4-7.6, filter through 0.2 µm pore membrane and store at 4 oC 
 
       Methods: 
        
       1. Cell stimulation  
1.1 Media preparation: prepare complete RPMI with PMA (20ng/ml), Ionomycin (2.66 µM), 
and Golgistop ( 100 times of the concentration of 4 µl in 6 ml media). 
1.2 Harvest cells into a conical tube. 
1.3 Fill the tube with RPMI for washing and centrifuge at 200 g for 5 min at RT. 
1.4 Resuspend in 2 ml RPMI. 
1.5 Add equal amount of Lympholyte-M, as described in Appendix B-1 step 3. 
1.6 Centrifuge at 500g for 15 min with break off. 
1.7 Remove the interface into a new tube, fill with RPMI, centrifuge at 300g for 5 min with 
break on. 
1.8 Cell counting. 
1.9 Resuspend cells at 2 × 106 cells/ml. 
1.10 Add 0.5 ml complete RPMI with PMA, Ionomycin to each well; add 0.5 ml cells to each 
well. 
1.11 For nonstimulated cells, add 0.5 ml complete RPMI into each well and add 0.5 ml cells 
1.12 Incubate the cells for 3h. 
1.13 After 3 h, add 10 µl of prepared GolgiStop (66.7 ul/ml) to each well of stimulated cells. 
Incubate for another 2 h. 
1.14 Meanwhile prepare anti-cytokine dilutions in staining buffer. Dim the light in the process. 
                       αIL-4-PE: 3 µg/ml 
                       αIFNγ-FITC: 2.4µg/ml 
                    
2 Harvest cells 
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Harvest cells from each well into corresponding small tubes and spin down the medium 
containing Golgistop. 
3 Block Fc receptors 
Add 100 µl Fc Block to each tube for 15 min at 4 oC, then wash cells with 1 ml staining buffer. 
4 Add 100 ul KJ1-26-PE-TC in staining buffer and incubate for 30 min at 4 oC in  
the dark. 
5 Wash cells two times with 1 ml staining buffer and pellet by centrifuging at 200g, 5 min, 4 oC. 
6 Fix and permeabilize cells 
Resuspend the cells in 250 µl BD Cytofix/Cytoperm solution for 20 min at 4 oC, then wash cells 
2 times in 1 ml 1X BD Perm/Wash solution, 200g, 5 min, 4 oC. 
7 Staining for intracellular cytokines 
Thoroughly resuspend fixed/permeabilized cells in 100 µl anti-cytokine antibody or appropriate 
negative control 
      Negative controls: unstimulated and unstained 
       Positive controls: Mick-2 cells, (Mouse intracellular cytokine positive control cells)  
       Fc Block (dilute stock to final concentration 5 µg/ml in staining buffer)     Pharmingen Cat#553142 
       KJ1-26-PE-TC monoclonal antibody to transgenic TcR, Caltag Laboratories #MM7506 (diluted to 2 
ug/ml in staining buffer before use) 
Incubate cells at 4 oC for 30 min in the dark. Wash cells 2 times with 1 ml BD Perm/Wash and 
resuspend in 500 µl Staining buffer. 
8 Flow cytometry 
Right before flow cytometric analysis, transfer the cells into 12×75 Polystyrene tubes for flow 
cytometry at room temperature.  
 
Samples: nonstained, stained with αIL-4-PE only, stained with αIFN-γ-FITC only, stained with 
αIL-4-PE and αIFN-γ-FITC. End point: cytokine profiles. 
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B-8. Determination of Percentage of Transgenic CD4+ T cells from Lymph Nodes in 
DO11.10 Mice  by Flow Cytometry 
 
Materials: 
Staining buffer: 
- DPBS, Invitrogen Corporation, 14190-144 
- 1% heat-inactivated FBS 
- 0.09% sodium azide 
- adjust to pH7.4-7.6, filter, store at 4 oC 
Fc Block (0.5 mg/ml)               Pharmingen  #553142 
- dilute to 5 µg/ml in staining buffer 
anti-CD4-FITC (stock 0.5 mg/ml)     Pharmingen  #553729 
anti-TcR-TC   (stock 0.2 mg/ml)       Caltag Laboratories  #MM7506 
2.0 ml microtubes, Fisher Scientific, #02-681-266 
12 × 75mm Polystyrene FACS tubes, Falcon, #352054 
Aluminum foil 
 
Protocol: 
1. prepare cell suspensions from lymph nodes as Appendix B-4. 
2. Resuspend cells at 2 × 106 cells/ml in PBS. 
3. Add 500 µl cells to 1.5 ml centrifuge tubes. 
4. Centrifuge at 200g for 5 min at 4 oC. 
5. Aspirate. 
6. Resuspend cells in 100 µl Fc Block (5 µg/ml) and and incubate at 4 oC for 15 min. 
7. Add 1 ml staining buffer and centrifuge at 200g for 5 min at 4 oC. 
8. Aspirate and resuspend cell pellets in 100 ul antibody diluted in staining buffer (anti-CD4 dilute to 5 
µg/ml, anti-TcR-Tc dilute to 2 µg/ml) and incubate in dark at 4 oC for 30 min. 
9. Wash with 1 ml staining buffer twice. 
10.  Resuspend in 500 µl staining buffer and transfer to FACS tubes at room temperature.  
11.  Promptly take samples for flow cytometer analysis. End point: percentage of CD4+, TCR+ cells. 
 
 
 
 
Follow the technical data sheet. 
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B-9. CFSE Labeling to analyze cell proliferation 
 
Materials: 
PBS/0.1% BSA 
Carboxyfluorescein Diacetate, Succinimidyl Ester (CFSE) (Molecular probes V-12883) 
RPMI 1640/10% FBS 
2.0 ml microtubes 
12 × 75 mm Polystyrene FACS tubes for flow cytometer 
Aluminum foil  
 
Protocol: 
1. Resuspend purified CD4+ T cells in PBS/0.1% BSA at a final concentration of 2 × 106 cells/ml in a 15 
ml conical tube. 
2. Add 1 µl of 10 mM CFSE to the tube. Vortex immediately for a few seconds. Incubate at 37 oC for 10 
min (to prepare 10 mM CFSE, add 90 µl of DMSO into one vial of CFSE). 
3. Add 5 vol ice-cold RPMI 1640/10% FBS according to the vol used as step 1 and incubate for 5 min 
on ice. 
4. Wash cells three times with PBS, centrifuge at 200g for 5 min at room temperature. 
5. Resuspend cells at 2 × 106 cells/ml in PBS/0.1% BSA and add 500 µl to the FACS tubes, wrap with 
aluminum foil, keep at room temperature, bring to Dr. Smith’s lab.  End point: to detect CFSE 
positive cells. 
 
 
 
Follow the technical data sheet from the company. 
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B-10. Diagram for Adoptive Transfer Dietary Study 
 
Experimental Design: 
 
DO11.10 mice    CO (40)                        
                                                        1 wk CO diet            2 wk CO diet                       
                           FO (22)                                                                 
                                             1 wk CO diet            2 wk FO diet                     transfer to diet-     
matched B10.D2 
mice (4 each group) 
 
B10.D2 mice      CO (4) 
                                                      1wk CO diet                  2 wk CO diet               1d CO               3d  CO 
                            FO (4)  
                                                      1wk CO diet                   2 wk FO diet              1d FO                3d FO 
Immunization s.c. 
with Complete 
Freund’s Adjuvant 
(CFA), Sigma, #F-
5881 
3 immunized in each 
group 
1 unimmunized  
 
Kill 
Kill, isolate CD4+ T cells, 
label with CFSE 
 
                            
 
 
 
 
 
 
 
 
 
 
 
LITERATURE  CITED: 
(49) Kearney, E. R., Pape, K. A., Loh, D. Y. & Jenkins, M. K. (1994) Visualization of peptide-specific T 
cell immunity and peripheral tolerance induction in vivo. Immunity 1: 327-339. 
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1. CD4+ T cells isolation. Same as described in Appendix B-4 and resuspended at 3x107 cells/ml in sterile 
PBS. 
 
 
2. CFSE lableing of CD4+ T cells 
 
Materials: 
BSA: IgG free, Boehringer Mannheim Laboratory Reagents, #100018 
PBS/0.1% BSA 
CFSE (Molecular probes V-12883) 
½ cc U100 insulin syringe, BD.  
RPMI 1640/10% FBS 
2.0 ml microtubes 
12 × 75 mm Polystyrene FACS tubes for flow cytometer 
Aluminum foil  
 
Methods: 
1. Resuspend cells (3x107 cells/ml) in PBS containing 0.1% BSA. 
2.Add 1 µl of 10 mM CFSE in the tube. Incubate at 37 oC for 10 min (to prepare 10 mM CFSE, add 90 µl 
of DMSO into one vial of CFSE). 
3.Add 5 vol ice-cold RPMI 1640/10% FBS and incubate for 5 min on ice. 
4.Wash cells three times with culture medium or PBS. 
5.Resuspend cells at 3 × 107 cells/ml in PBS/0.1% BSA and load 100 µl into 30 gauge insulin syringes.   
6.Put syringes on ice and bring over to LARR for tail injection. 
 
3. Immunization 
 
Materials: 
Sterile PBS 
OVA peptide 
Complete Freund’s adjuvant (CFA),   Sigma #F-5881 
Micro-emulsifying needles 73 mm, Popper & Sons, Inc, New Hyde Park, NY #7973 
3ml BD Luer-Lok syringe, #309585 
1ml BD Luer Lok syringe, #309628 
25G 5/8 inch needle BD #305122 
 
Methods: 
1. One day after tail injection, prepare 0.5 ml of OVA peptide with sterile PBS (final concentration 
6mg/ml) 
2. Emulsify with 0.5 ml of CFA (Add 0.5 ml of OVA peptide in a syringe at one end of the mixing tube, 
then add 0.5 ml of CFA to another syringe attached to the other end of the mixing tube, push through the 
micro-emulsifying needle several times until it is really hard to push-which means it is ready). 
3. Inject subcutaneously in a total volume of 0.1 ml distributed between two dorsal sites on the back with 
25G 5/8 inch needle. 
 
 
4. Flow detection of antigen-specific cells 
 
Materials: 
0.2 um Nylon membrane filter, Gelman Laboratory, #4433 
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Staining buffer: 
- DPBS 
- 1% heat-inactivated FBS 
- 0.09% sodium azide 
- adjust to pH7.4-7.6, filter, store at 4 oC 
Fc Block (0.5 mg/ml)               Pharmingen  #553142 
- dilute to 5 µg/ml in staining buffer 
anti-TcR-TC   (0.2 mg/ml)       Caltag Laboratories  #MM7506 
1.5 ml microtubes 
12 × 75mm Polystyrene FACS tubes 
Aluminum foil 
 
Methods: 
1. Harvest brachical and inguinal lymph nodes from recipient B10.D2 mice  
2. Homogenize and wash once as Appendix 4. 
3. Resuspend cells at 2 × 106 cells/ml in PBS. 
4. Add 500 µl cells to 1.5 ml centrifuge tubes. 
5. Centrifuge at 200g for 5 min at 4 oC. 
6. Aspirate. 
7. Resuspend cells in 100 µl Fc Block (5 µg/ml) and incubate at 4 oC for 15 min. 
8. Add 1 ml staining buffer and centrifuge. 
9. Resuspend in 100 µl antibody diluted in staining buffer (anti-CD4 dilute to 5 µg/ml, anti-TcR-Tc dilute 
to 2 µg/ml) and incubate in dark at 4 oC for 30 min. 
10.Wash with 1 ml staining buffer twice. 
11.Resuspend in 500 µl staining buffer and transfer to FACS tubes at room temperature, wrap in 
aluminum foil.  
12.  Promptly take samples for flow cytometer analysis. 
 
 
LITERATURE CITED: 
(49) Kearney, E. R., Pape, K. A., Loh, D. Y. & Jenkins, M. K. (1994) Visualization of peptide-specific T 
cell immunity and peripheral tolerance induction in vivo. Immunity 1: 327-339. 
  
(52) Lyons, A. B. (2000) Analysing cell division in vivo and in vitro using flow cytometric measurement 
of CFSE dye dilution. J Immunol Methods 243: 147-154. 
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B-11. Protocol for Autologous Mouse Serum Collection 
(from Dr. Fritsche-----12/02) 
 
Materials: 
B-D vacutainer SST tubes, 2.5 mL w/clot activator (Fisher cat # 02-688-29) 
Costar 8110 mStar 0.22 micro sterile filter (Fisher # 07-200-370) 
Sterile 1.5 mL microfuge tubes w/ snap-on lids 
Sterile syringes w/o needles, 3 mL 
1 cc tuberculin syringes w/ fixed 25 G needle 
 
Protocol: 
1. Sacrifice mice with CO2. Collect blood from mice via cardiac puncture using paster pipets. 
2. Immediately transfer blood into one of the B-D SST tubes.  
3. Add blood from other mice within the same dietary treatment group to the same tube as space will 
allow. 
4. Turn on waterbath and set the temperature to 56 oC. 
5. Allow blood to clot in tubes for 1-2 hr at room temperature. 
6. Spin tubes (1000 g for 15 min). 
7. In the laminar flow hood, attach a 0.22 mm filter to a 3 mL syringe after the plunger has been 
removed. 
8. Carefully decant the sera from each tube into a syringe, then use the plunger to slowly force the sera 
through the filter and into a sterile microfuge tube. 
9. The sterile filtered sera should be heat-inactivated by placing in the 56 oC water bath for 30 min. 
10. After inactivation, the sera should be cooled on ice, then used or stored at –80 oC (Sera should be 
good for up to 6 months, but the fresher the sera the better, particularly when mice are fed high PUFA 
diets. 
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B-12. Staining of Surface CD25 (IL-2 receptor α chain) 
 
Materials: 
Staining buffer: 
- DPBS 
- 1% heat-inactivated FBS 
- 0.09% sodium azide 
-adjust to pH7.4-7.6, filter, store at 4 oC 
0.2 µM HT Tuffryn low protein binding membrane filter, PALL life scientific, #4192 
Fc Block (stock 0.5 mg/ml)                       PharMingen  #553142 
- dilute to 5 µg/ml in staining buffer 
anti-CD25-PE  (stock 0.2 mg/ml, dilute to 2 ug/ml in staining buffer before use)   PharMingen   #553866   
7-amino-actinomycin D (7-AAD, use stock directly, do not need dilution)        PharMingen  # 559925 
1.5 ml microtubes 
12 × 75mm Polystyrene tubes 
Aluminum foil 
 
 
Methods: 
     Controls:  
      Unstained,  
      Stained with 7-AAD only 
      Stained with anti-CD25-PE only 
 
1. Resuspend cells at 2 × 106 cells/ml in PBS . 
2. Add 500 µl cells to 1.5 ml centrifuge tube. 
3. Centrifuge at 200g for 5 min. 
4. Aspirate. 
5. Resuspend in 100 µl Fc Block, incubate at 4 oC for 15 min. 
6. Add 1 ml staining buffer, centrifuge at 200g for 5 min, aspirate. 
7. Add 100 µl anti-CD25-PE (diluted to 2 µg/ml final concentration in staining buffer, incubate at 4 oC  
for 30 min in dark. 
8. Wash twice with 1 ml staining buffer. 
9. Resuspend cells in 80 µl  staining buffer, then add 20 µl stock 7-AAD, gently vortex, incubate at RT 
in dark for 10 min. 
10. Add 400 µl staining buffer. 
11. Transfer to FACS tubes, at room temperature, wrap in aluminum foil, bring to Dr.Smith’s lab. End 
point: living CD25+ cells . 
 
 
Follow the technical data sheet from BD Phaemingen
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B-13. Apoptosis assayed by Annexin V-FITC/PI staining for flow Cytometry 
 
Materials: 
AnnexinV Kit, BD PharMingen, #6693KK 
1X PBS, stored at 4 oC 
1.5 ml tubes 
12x75mm Polystyrene tubes (for flow cytometry) 
Aluminum foil 
 
Methods: 
1.    Harvest cells following Th1 polarization, wash once and resuspend cells at 2x106 cells/ml in PBS, add 
1ml to 1.5 ml tube. 
2.    Centrifuge at 200g, 5 min. 
3.    Aspirate supernatant. 
4.    Resuspend cells in 100 ul of 1x Binding buffer from the kit and transfer to 12x75 mm polystyrene   
tubes. 
5.    In the dark, add to each tube: 5 µl of Annexin V-FITC, 2 µl of Propidium Iodide. 
6. Resuspend after adding each solution. 
7. Wrap tubes in aluminum foil and incubate in the dark for 15 min at room temperature 
8. After 15 min incubation, add 400 µl of 1 X Binding Buffer to each tube. 
9. Cover tubes in aluminum foil. 
10. Promptly take samples to Dr. Smith for flow analysis. (Samples should be analyzed within 1 hour of 
staining)  
 
 
LITERATURE CITED: 
(84) Switzer, K. C., McMurray, D. N., Morris, J. S. & Chapkin, R. S. (2003) (n-3) Polyunsaturated fatty 
acids promote activation-induced cell death in murine T lymphocytes. J Nutr 133: 496-503. 
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B-14. Dietary Lipid Extraction 
(from Kirsten C. Switzer) 
 
 
1. Obtain prepared 12 ml leak-proof tubes. 
If not available: Put acetone into 12 ml glass screw-top tubes. Mark the acetone level. Close lids 
tightly and place in 80 oC oven for 1 h. Remove and note the acetone level. Do not use the tubes that 
evaporated acetone. 
2. Pour off acetone from tubes and drain upside down. 
3. Put each diet (0.5-1 g, amount not critical) into 25 ml glass screw-cap tubes. 
4. Add 5 ml Folch reagent (CHCl3 /Methanol – 2:1 v:v) to each tube. 
5. Add 1 ml 0.1 M cold KCl to each tube. 
6. Vortex for 1 min. 
7. Centrifuge at 4000 rpm for 5 min at 4 oC. Make sure to put glass tubes in a rubber holder before 
placing in the centrifuge. 
8. Transfer the lower phase to a 12 ml leak-proof tube-use a Pasteur pipet bubble through the top layer 
so as not to contaminate the extraction. 
9. Dry down with Nitrogen. 
-wipe each needle 
-do not put the needle into the solution 
-do not turn the Nitrogen on too high otherwise the solution will bubble out 
 -dry until no liquid remains 
10. Add 3 ml fresh 6% HCl/MeOH to each tube (for 20 ml, use 1.2 ml concentrated HCl in 18.8 ml 
MeOH. This solution is light sensetive, so put foil around the container). 
11. Flush with Nitrogen and cap tightly. 
12. Vortex for 1 min. 
13. Put in an 80 oC oven for 14-16 h (overnight). 
14. Take tubes out of oven, put on ice. 
15. Add 1 ml of 0.1 M KCl and 2 ml Hexane to each tube. 
16. Vortex for 1 min. 
17. Label 4 ml glass screw-top vials: “FAME” for Fatty Acid Methyl Esters. Make sure to replace normal 
black lids with green lids with Teflon for organic solvents. 
18. Transfer upper phase to 4 ml glass vials. 
19. Dry down with Nitrogen-see step 9. 
20. Redissolve the FAME extraction into 500 µl of CH2Cl2. Use extra if the FAME looks concentrated 
(yellowish). Remove 100 µl of the concentrated oil and add it to 1 ml of CH2Cl2. 
21. Flush with Nitrogen. 
22. Store at –20 oC or analyse immediately on GC. 
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